Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device.
Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
{"xsrfToken":"61859f911bf96ad162cabd6ebca1a2efb5768e01_lout","branding":{"id":"1","key":"cs","name":"DREAM Resource Request Portal","portalBaseUrl":"/servicedesk/customer/portal/1","logoUrl":"/rest/servicedesk/1/customer/viewport-resources/portal-logo/1/1","theme":{"headerBGColor":"#ffffff","headerLinkColor":"#292929","headerLinkHoverColor":"#cf3035","headerLinkHoverBGColor":"#cf3035","headerBadgeColor":"#cf3035"}},"helpCenterBranding":{"logoUrl":"https://api.media.atlassian.com/file/98f2a623-c078-4da3-bfa6-b00566f4554f/image/cdn?token=eyJhbGciOiJIUzI1NiJ9.eyJpc3MiOiIzNTY0ZjllMS0xYmIxLTRiYWUtODhmYy00OGFkN2RmZTdiYzMiLCJhY2Nlc3MiOnsidXJuOmZpbGVzdG9yZTpmaWxlOjk4ZjJhNjIzLWMwNzgtNGRhMy1iZmE2LWIwMDU2NmY0NTU0ZiI6WyJyZWFkIl19LCJleHAiOjE3NzkyODg2ODMsIm5iZiI6MTc3OTI4ODA4M30.cpi-5IRT5zSkchEKdqgg3tVBxS90Ox5P_UJI_ghsqtY&client=3564f9e1-1bb1-4bae-88fc-48ad7dfe7bc3&mode=fit","logoId":"98f2a623-c078-4da3-bfa6-b00566f4554f","isLogoAvailable":true,"helpCenterTitle":"Welcome to Lupus Nexus Request Center","sharedPortalName":"Request Center","translations":{"en-US":{"helpCenterTitle":"Welcome to Lupus Nexus Request Center","sharedPortalName":"Request Center","localeDisplayName":"English (United States)"}},"canEditAnnouncement":false,"siteDefaultLanguageTag":"en-US","userLanguageTag":"en-US","portalThemeColor":"#6d737a","helpCenterTitleColor":"#7a48bb","bannerMediaApiUrl":"https://api.media.atlassian.com/file/235a805c-1d82-475d-91a1-13ee3b9293f8/image/cdn?token=eyJhbGciOiJIUzI1NiJ9.eyJpc3MiOiIzNTY0ZjllMS0xYmIxLTRiYWUtODhmYy00OGFkN2RmZTdiYzMiLCJhY2Nlc3MiOnsidXJuOmZpbGVzdG9yZTpmaWxlOjIzNWE4MDVjLTFkODItNDc1ZC05MWExLTEzZWUzYjkyOTNmOCI6WyJyZWFkIl19LCJleHAiOjE3NzkyODg2ODMsIm5iZiI6MTc3OTI4ODA4M30.yokjlRA9nA_U0sliM1v9banVE65TwpNQ4IYvxrg4UDI&client=3564f9e1-1bb1-4bae-88fc-48ad7dfe7bc3&height=300&mode=fit","bannerMediaApiFileId":"235a805c-1d82-475d-91a1-13ee3b9293f8","useDefaultBanner":false,"isBannerAvailable":true,"hasTopBarBeenSplit":false},"portal":{"id":"1","key":"cs","projectId":10001,"serviceDeskId":1,"name":"DREAM Resource Request Portal","description":"<p>Welcome! You can make a Resource Request below.</p>","portalBaseUrl":"/servicedesk/customer/portal/1","reqTypes":[{"id":"9","name":" DREAM Access Application","descriptionHtml":"","callToAction":" DREAM Access Application","introHtml":"<p>Submit a Request for Sample or Data Resources</p>","icon":10503,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10503","groups":[1],"key":""},{"id":"10","name":"DREAM Information Request","descriptionHtml":"<p>Please fill in the form below to ask about the DREAM.</p>","callToAction":"DREAM Information Request","introHtml":"<p>This request is to learn more or ask a question to the DREAM Support Team</p>","icon":10503,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10503","groups":[1],"key":""},{"id":"5","name":"Emailed request","descriptionHtml":"","callToAction":"Emailed request","introHtml":"<p>Request received from your email support channel.</p>","icon":10527,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10527","groups":[],"key":""},{"id":"2","name":"Licensing and billing questions","descriptionHtml":"","callToAction":"Licensing and billing questions","introHtml":"<p>Choose this if you have questions about licensing or billing.</p>","icon":10536,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10536","groups":[],"key":""},{"id":"4","name":"Other questions","descriptionHtml":"","callToAction":"Other questions","introHtml":"<p>Don't see what you're looking for? Select this option and we'll help you out.</p>","icon":10549,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10549","groups":[],"key":""},{"id":"3","name":"Product trial questions","descriptionHtml":"","callToAction":"Product trial questions","introHtml":"<p>Trying out our product and want more information? Select this and we'll be happy to answer your questions.</p>","icon":10541,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10541","groups":[],"key":""},{"id":"6","name":"Report a bug","descriptionHtml":"","callToAction":"Report a bug","introHtml":"<p>Tell us the problems you're experiencing.</p>","icon":10545,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10545","groups":[],"key":""},{"id":"7","name":"Suggest a new feature","descriptionHtml":"","callToAction":"Suggest a new feature","introHtml":"<p>Let us know your idea for a new feature.</p>","icon":10535,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10535","groups":[],"key":""},{"id":"8","name":"Suggest improvement","descriptionHtml":"","callToAction":"Suggest improvement","introHtml":"<p>See a place where we can do better? We're all ears.</p>","icon":10539,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10539","groups":[],"key":""},{"id":"1","name":"Technical support","descriptionHtml":"","callToAction":"Technical support","introHtml":"<p>Need help installing, configuring, or troubleshooting? Select this to request assistance.</p>","icon":10520,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10520","groups":[],"key":""}],"reqGroups":[{"id":1,"name":"Submit a Resource Request"}],"orderMapping":{"1":[10,9]},"kbs":{"kbEnabled":false,"serviceDeskId":-1},"createPermission":true,"portalAnnouncement":{"portalId":1,"canEditAnnouncement":false,"canAdministerProject":false,"portalProjectKey":"DR","userLanguageHeader":"","userLanguageMessageWiki":"","defaultLanguageHeader":"","defaultLanguageMessage":"","defaultLanguageDisplayName":"English (United States)","isUsingLanguageSupport":false,"translations":{}},"canViewCreateRequestForm":true,"isProjectSimplified":false,"mediaApiUploadInformation":{"token":"eyJhbGciOiJIUzI1NiJ9.eyJpc3MiOiIzNTY0ZjllMS0xYmIxLTRiYWUtODhmYy00OGFkN2RmZTdiYzMiLCJhY2Nlc3MiOnsidXJuOmZpbGVzdG9yZTp1cGxvYWQ6KiI6WyJyZWFkIiwiY3JlYXRlIiwidXBkYXRlIl0sInVybjpmaWxlc3RvcmU6Y29sbGVjdGlvbjp1cGxvYWQtdXNlci1jb2xsZWN0aW9uLS04MzQ0Nzc2MzgiOlsicmVhZCIsImNyZWF0ZSIsInVwZGF0ZSJdLCJ1cm46ZmlsZXN0b3JlOmNodW5rOioiOlsicmVhZCIsImNyZWF0ZSJdfSwiZXhwIjoxNzc5Mjg5MjgzLCJuYmYiOjE3NzkyODgwODMsImFub25JZCI6ImFub24tdXNlciIsImh0dHBzOi8vaWQuYXRsYXNzaWFuLmNvbS9hcHBBY2NyZWRpdGVkIjpmYWxzZX0.9ciJgS1xkNuWVspimVFpn3W1h_tmHRKp7GpvZyRdlao","targetCollection":"upload-user-collection--834477638","endpointUrl":"https://api.media.atlassian.com","clientId":"3564f9e1-1bb1-4bae-88fc-48ad7dfe7bc3","tokenDurationInMins":20}},"reqCreate":{"id":9,"projectId":10001,"issueType":{"id":"10007","name":"New Feature"},"form":{"name":" DREAM Access Application","descriptionHtml":"","callToAction":" DREAM Access Application","intro":"<p>Submit a Request for Sample or Data Resources</p>","instructions":"","icon":10503,"iconUrl":"https://lupusnexus.request.lupusresearch.org/rest/servicedeskapi/requesttype/icon/type/SD_REQTYPE/id/10503","key":""},"fields":[{"fieldType":"text","fieldId":"email","fieldConfigId":"","label":"Email confirmation to","description":"","descriptionHtml":"","required":true,"displayed":true,"presetValues":[]}],"userOrganisations":[],"canBrowseUsers":false,"requestCreateBaseUrl":"/servicedesk/customer/portal/1/create/9","requestValidateBaseUrl":"/servicedesk/customer/portal/1/validate/9","calendarParams":{"firstDay":0,"date":"2026-05-20T10:41:24-0400","useISO8601WeekNumbers":false,"dateIfFormat":"%e/%b/%y","dateTimeIfFormat":"%e/%b/%y %I:%M %p","timeFormat":"12"},"kbs":{"kbEnabled":false,"serviceDeskId":-1},"canRaiseOnBehalf":false,"canSignupCustomers":false,"canCreateAttachments":true,"attachmentRequiredField":false,"hasGroups":true,"canSubmitWithEmailAddress":false,"showRecaptcha":true,"siteKey":"6LePXLkdAAAAAF4gCNalrL1IvZcqbNbZf_Zakudd","mediaApiUploadInformation":{"token":"eyJhbGciOiJIUzI1NiJ9.eyJpc3MiOiIzNTY0ZjllMS0xYmIxLTRiYWUtODhmYy00OGFkN2RmZTdiYzMiLCJhY2Nlc3MiOnsidXJuOmZpbGVzdG9yZTp1cGxvYWQ6KiI6WyJyZWFkIiwiY3JlYXRlIiwidXBkYXRlIl0sInVybjpmaWxlc3RvcmU6Y29sbGVjdGlvbjp1cGxvYWQtdXNlci1jb2xsZWN0aW9uLS04MzQ0Nzc2MzgiOlsicmVhZCIsImNyZWF0ZSIsInVwZGF0ZSJdLCJ1cm46ZmlsZXN0b3JlOmNodW5rOioiOlsicmVhZCIsImNyZWF0ZSJdfSwiZXhwIjoxNzc5Mjg5Mjg0LCJuYmYiOjE3NzkyODgwODQsImFub25JZCI6ImFub24tdXNlciIsImh0dHBzOi8vaWQuYXRsYXNzaWFuLmNvbS9hcHBBY2NyZWRpdGVkIjpmYWxzZX0.pTsG4n0k5i6r7w6DpL1wadHkg_a5eo2pV4nU9pZWFBs","targetCollection":"upload-user-collection--834477638","endpointUrl":"https://api.media.atlassian.com","clientId":"3564f9e1-1bb1-4bae-88fc-48ad7dfe7bc3","tokenDurationInMins":20},"hasProformaForm":true,"proformaTemplateForm":{"id":7805372048849154,"updated":"2026-05-19T19:45:02.141247164Z","publish":{"jira":{"submitOnCreate":true,"validateOnCreate":true},"portal":{"portalRequestTypeIds":[9],"submitOnCreate":true,"validateOnCreate":true}},"design":{"settings":{"templateId":7805372048849154,"name":"Resource Request V5","submit":{"lock":false,"pdf":true},"templateFormUuid":"ce7605d7-5892-4597-838a-8cbc2367fcac"},"layout":[{"version":1,"type":"doc","content":[{"type":"paragraph","content":[]},{"type":"paragraph","content":[]},{"type":"heading","attrs":{"level":2,"localId":"1b226e20-4ba9-496e-8e63-7b62266bd5bc"},"content":[{"type":"text","text":"Access and Resource Request","marks":[{"type":"strong"}]}]},{"type":"heading","attrs":{"level":2,"localId":"58e6c50c-bec3-44a6-a18c-54002548c345"},"content":[{"type":"text","text":"Contact Information","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"42287ce5-0daa-42cf-8d6d-6b9576c92bd6"},"content":[{"type":"text","text":"Let’s start with the basics."}]}]},{"version":1,"type":"doc","content":[{"type":"paragraph","content":[]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":50},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":1},"layout":"default","localId":"18afaf6e-8cbd-42fb-bed1-4229656b8845"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":18},"layout":"default","localId":"0591354d-caf2-475b-b415-81ba8bb4995c"}}]},{"type":"layoutColumn","attrs":{"width":50},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":5},"layout":"default","localId":"e3101f42-6448-490b-b54f-a08ecf04f77b"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":7},"layout":"default","localId":"60f46de1-c8c8-4d6a-acfa-25a289b4f712"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":52},"layout":"default","localId":"ea4095dd-a1e5-4725-9ec8-21d9c0f31e40"}}]}]},{"type":"heading","attrs":{"level":2,"localId":"ef62dea6-ed6f-4114-80c1-49f7eae293ce"},"content":[{"type":"text","text":"Organization Information","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"561c21ce-4ff6-4a78-8622-20d6f3b8f32e"},"content":[{"type":"text","text":"Where are you from and what are your technical capabilities?"}]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":50},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":19},"layout":"default","localId":"9a851fee-957e-48ab-83f0-b87812be5e2f"}},{"type":"paragraph","content":[]}]},{"type":"layoutColumn","attrs":{"width":50},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":15},"layout":"default","localId":"5dbe1a8b-a390-4eac-ba29-75540f52e955"}}]}]},{"type":"paragraph","content":[]},{"type":"paragraph","content":[]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":95},"layout":"default","localId":"d873e962-8ce8-4207-9f7e-1f43c8c10484"}},{"type":"paragraph","content":[]}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"d3d35951-9b6d-4466-81fe-7012509edcff"},"content":[{"type":"text","text":"Funding","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"370853ea-22f4-413a-aedb-55480b50f125"},"content":[{"type":"text","text":"Enter the following information on funding."}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":90},"layout":"default","localId":"d50e0e22-b554-43b7-b0fb-b5c1dd54dbd8"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":79},"layout":"default","localId":"56735811-7f07-490c-95f6-74b71a7913bd"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":98},"layout":"default","localId":"f1178cc6-355c-4cef-87cb-197bc9b754b6"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":81},"layout":"default","localId":"1e0f8963-9b7a-4501-bca1-070c2fb3a61d"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":83},"layout":"default","localId":"634abb61-67de-4fde-8a7e-241cb3ae773c"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":84},"layout":"default","localId":"4366e8db-d996-4ba4-b3e0-41883f4b5259"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":237},"layout":"default","localId":"ab0e4018-bc10-4136-a2f3-191a3ef2acd5"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":86},"layout":"default","localId":"1ba4eb0d-8afc-44be-a2c1-23890f9be205"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":89},"layout":"default","localId":"9880e7d2-b449-4c4b-aeab-f33c9a477eb7"}},{"type":"paragraph","content":[]}]},{"version":1,"type":"doc","content":[{"type":"paragraph","content":[]},{"type":"heading","attrs":{"level":2,"localId":"3d6d8459-eb48-419c-a4f4-995d9c5d974b"},"content":[{"type":"text","text":"Project Information","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"a729c363-1ff2-4a4b-ac2d-60814360c68e"},"content":[{"type":"text","text":"What type of lupus research are you performing?"}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":20},"layout":"default","localId":"180acefa-d4e8-4a3a-92f5-962bdee231eb"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":21},"layout":"default","localId":"94547d37-2b37-4349-8cae-fe540cd8132d"}},{"type":"paragraph","content":[]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":96},"layout":"default","localId":"41e378f9-5c25-4aad-84ca-46881144b562"}},{"type":"paragraph","content":[]}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"910bc439-f4c1-4e6f-8026-284b0f5f5a97"},"content":[{"type":"text","text":"Tier 1: Clinical and Real-World Data (CRWD)","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"51ffa63e-a0a8-439f-84e8-78553193ce9d"},"content":[{"type":"text","text":"Tier 1 Data includes all clinician- and patient-reported outcome data from samples associated with the parameters below."}]},{"type":"paragraph","content":[]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":25},"layout":"default","localId":"c9ebf629-87ce-48d7-8328-1474c97d5c74"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":26},"layout":"default","localId":"2a497f04-fef5-4a80-9af4-d27df1f630bb"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":45},"layout":"default","localId":"b0985f71-beeb-45dd-9e38-9133cc30710e"}},{"type":"paragraph","content":[]}]}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":67},"layout":"default","localId":"ab2f556e-60d0-4978-ac54-4dcc76bcab5c"}}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"b1734bc4-c13a-47c5-a4c9-e270c7faae02"},"content":[{"type":"text","text":"Tier 2: Biomarker Data (Scientific Data)","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"0e569c88-bc9a-4b62-94a1-4d479112f112"},"content":[{"type":"text","text":"Tier 2 Data includes scientific (testing results) from samples associated with the parameters below."}]},{"type":"paragraph","content":[]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":46},"layout":"default","localId":"02ec0571-7407-4f65-88f2-354e2569c679"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":47},"layout":"default","localId":"29df47cc-b1d8-4371-b088-8b492f756189"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":48},"layout":"default","localId":"0bbaa0fe-a638-472d-b202-e021d440c4c8"}}]}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":104},"layout":"default","localId":"b91efe26-7c3f-4f45-b99a-fe6c7865becc"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":107},"layout":"default","localId":"49420e6e-10c0-491e-9c35-9ca0fea8560a"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":109},"layout":"default","localId":"d83dd6a2-a614-42aa-bd27-04950a48747c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":111},"layout":"default","localId":"68ba189f-ded2-4686-b2d7-d9bef9cb945c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":113},"layout":"default","localId":"543bb0d6-24c9-45ff-b834-f63728f6b894"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":115},"layout":"default","localId":"869e43f2-638c-47fb-bcf6-b4ae7eb26526"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":117},"layout":"default","localId":"8d9b8dcf-a84f-4536-8636-26fee9c6ab0c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":119},"layout":"default","localId":"5f38c5c9-7f53-4d6f-ba97-e11b71cd39a4"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":121},"layout":"default","localId":"7f4c96a3-f914-4f19-ae68-a34276385fd8"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":123},"layout":"default","localId":"0102887a-dfbe-4398-b528-59b1978c4f03"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":125},"layout":"default","localId":"081536ac-0729-45c9-bb2a-35e26f780d05"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":127},"layout":"default","localId":"8aa9803d-5596-4859-b633-a168e27e55de"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":129},"layout":"default","localId":"97b1e421-a262-466a-8ccb-c53bea658c89"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":131},"layout":"default","localId":"1c8cbd5a-cbcf-486c-8a6a-86984db7df96"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":133},"layout":"default","localId":"4d039264-aff0-4b4b-9106-63853147b3dd"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":135},"layout":"default","localId":"d644760c-fe86-49be-9011-208656565935"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":137},"layout":"default","localId":"0147a8e0-43de-451f-8e9e-236bd6fb8584"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":139},"layout":"default","localId":"7ea24e60-a411-4fa9-8b97-9ad725448349"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":141},"layout":"default","localId":"cd124524-f881-4e70-923d-a0c2eb36bb3a"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":143},"layout":"default","localId":"3a4a3f46-0576-42b2-87c1-7b9a06678605"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":145},"layout":"default","localId":"7a46e1ce-744c-44ec-8476-f6929627945f"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":57},"layout":"default","localId":"7d57aa65-2a7b-4a0b-a504-aac4de71034d"}}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"e398cb8d-798e-44e1-95aa-51f15a2bca44"},"content":[{"type":"text","text":"Tier 3: Clinical/Real-World Data & Biomarker Data","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"0ef37cda-3b08-4e38-8dfe-3bb727a37197"},"content":[{"type":"text","text":"Tier 3 Data includes all clinician- and patient-reported outcome data and all scientific data (testing results) from samples associated with the parameters below."}]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":49},"layout":"default","localId":"ba95874f-8498-45e2-8e70-e1d14ce47ca8"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":50},"layout":"default","localId":"5972264e-c8ad-4d4a-9018-ca51fdd0f99e"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":51},"layout":"default","localId":"aae93c1c-75a2-40eb-8e30-447fdd666546"}}]}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":147},"layout":"default","localId":"1b86882e-fa61-4de3-b98c-ed112effad38"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":149},"layout":"default","localId":"b17655d5-a498-4e3f-b668-77ab93c421a6"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":151},"layout":"default","localId":"497a93c9-c3e8-4d02-9c4b-7e33dbcfc54e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":153},"layout":"default","localId":"97799729-c6aa-4413-bd14-a5bdffd57826"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":155},"layout":"default","localId":"d25c2362-6eea-4f9f-92d4-3dfbb8925738"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":157},"layout":"default","localId":"4baa0995-b9a0-434f-b2d4-17778026c71e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":159},"layout":"default","localId":"8f79dd8d-a596-4ed8-b229-faed9a76958e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":161},"layout":"default","localId":"25e4fa75-6344-4c75-a5c1-4f88b184d6c7"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":164},"layout":"default","localId":"9163134d-d363-4379-8248-2d1ca595a8a4"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":166},"layout":"default","localId":"b43a9f78-4879-4120-82c8-da4c84a28e88"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":168},"layout":"default","localId":"71b6602c-710c-4836-9f79-521af63e9c33"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":170},"layout":"default","localId":"8acbafe8-cc3f-4741-9545-1877d6673686"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":172},"layout":"default","localId":"66ceb283-3a6b-4fdc-92aa-0c14e89bf0dc"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":174},"layout":"default","localId":"19cf9018-0112-4e81-8508-a9860f82f0ec"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":176},"layout":"default","localId":"486c3b95-8f1d-454a-ade8-61fed135acf9"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":178},"layout":"default","localId":"d30807b8-2c4f-4f69-bbd2-f55e8dfb7b70"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":180},"layout":"default","localId":"b1a00578-f4d9-42a1-b432-10226c11e3e5"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":182},"layout":"default","localId":"d67ee6ac-a7bf-42c5-9534-8c169640c956"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":184},"layout":"default","localId":"b81ce732-9c94-467f-b6dd-80b5f950fe2b"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":186},"layout":"default","localId":"9458593a-287a-4edf-98e4-783750e429bd"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":188},"layout":"default","localId":"b57d32be-f302-4cb4-a502-84714d44771e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":68},"layout":"default","localId":"3786461c-c0bc-437b-ba12-a7c1fd9fb1aa"}}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"e398cb8d-798e-44e1-95aa-51f15a2bca44"},"content":[{"type":"text","text":"Electronic Medical Record Data","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"cab3377b-aa96-4de4-a305-6b637b53f4d4"},"content":[{"type":"text","text":"Electronic Medical Record Data includes all available data from participant’s medical records."}]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":60},"layout":"default","localId":"e694a570-d7b6-497e-8b01-5b7016ca3f59"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":61},"layout":"default","localId":"53181c0c-e984-4c35-b467-4f03cacd4c06"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":62},"layout":"default","localId":"7a25c264-0689-4fa1-a05c-7b5daa84995c"}}]}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":69},"layout":"default","localId":"7a536924-b8ee-4c75-b92b-067a22f7c09a"}}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"e398cb8d-798e-44e1-95aa-51f15a2bca44"},"content":[{"type":"text","text":"Data Services","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"42273805-bf2c-4c42-84f7-b44aac189e24"},"content":[{"type":"text","text":"A request for technical assistance. "}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":64},"layout":"default","localId":"55a60bd9-13dc-4c1b-892c-3a530654b1f1"}},{"type":"paragraph","content":[]}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"1a8dd17f-d8e6-4920-82c0-c823b6d812ce"},"content":[{"type":"text","text":"Biosample Request","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"6571af88-b9fe-4667-a080-49e6e9f5c99f"},"content":[{"type":"text","text":"Please enter the information below to request specific scientific testing/results on DREAM samples. "}]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":29},"layout":"default","localId":"a6de2b5b-487c-4ace-a788-9a7b93bcccb2"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":38},"layout":"default","localId":"e5e5277e-2228-4cab-8338-7be1d9b5aa20"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":33},"layout":"default","localId":"fc872c5e-b1ee-46de-9f3a-f972b5e3b076"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":55},"layout":"default","localId":"fcec2065-85e9-4d65-a961-fffd72d96fd2"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":35},"layout":"default","localId":"9e0e8068-9502-4f97-9252-17820371200f"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":36},"layout":"default","localId":"d303a075-3b10-4cc2-86bb-491b62324281"}}]},{"type":"layoutColumn","attrs":{"width":66.66},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":59},"layout":"default","localId":"84dd0b1a-258a-43c2-9f15-8dcf6016d696"}}]}]}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":190},"layout":"default","localId":"5250c057-8a58-4ab5-ac9f-7cc93a97a442"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":192},"layout":"default","localId":"f508efd9-5c78-44a1-b4ae-2c57928c99f6"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":194},"layout":"default","localId":"0f1e76a0-93de-4aa2-bb27-a99f37aa115c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":196},"layout":"default","localId":"fd102f26-9d14-4cb4-8f18-97856510fae9"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":198},"layout":"default","localId":"e5824432-2128-4121-a4d7-757de95bb6f6"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":200},"layout":"default","localId":"03fc04d8-a618-46bd-bc24-9a1a11dd20c1"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":202},"layout":"default","localId":"f8330f3f-d516-4680-9381-9fbffda69c93"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":204},"layout":"default","localId":"dc974222-c661-404f-9c87-9fa74d4cd2a0"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":206},"layout":"default","localId":"c05eed18-87a3-482e-b6c4-cab00083a968"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":208},"layout":"default","localId":"de4bc66a-b962-4b6e-bc5b-664c676eea6e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":210},"layout":"default","localId":"bc885823-bd92-4034-a489-6ed6bd54d40b"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":212},"layout":"default","localId":"23942c06-ea91-45d5-a0ba-d9d54c03eb9c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":214},"layout":"default","localId":"dc0dedd9-691f-460e-840b-99ba6f53e14d"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":216},"layout":"default","localId":"1e119077-fbcb-4715-97d2-fba9218d98e5"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":218},"layout":"default","localId":"d2d548e5-8f2a-4aa5-88ec-054beea93692"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":220},"layout":"default","localId":"42886103-3857-4535-94cd-eba7a72db1cc"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":222},"layout":"default","localId":"8ca97437-b79b-4e82-8747-aac80614aa1c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":224},"layout":"default","localId":"a7379868-e121-49c3-8956-b677365d02ee"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":226},"layout":"default","localId":"ddde84da-9027-4bd6-92b8-bcf0b9031aa0"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":228},"layout":"default","localId":"c1073b48-645c-4aec-a65f-788d486f8108"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":234},"layout":"default","localId":"1f83d77f-511d-4690-ac48-2d92387e4f4c"}},{"type":"heading","attrs":{"level":2,"localId":"d3d35951-9b6d-4466-81fe-7012509edcff"},"content":[]},{"type":"paragraph","content":[]}]}],"conditions":{"124":{"i":{"co":{"cIds":{"123":["2"]}}},"o":{"sIds":["22"]},"t":"sh"},"175":{"i":{"co":{"cIds":{"174":["2"]}}},"o":{"sIds":["48"]},"t":"sh"},"227":{"i":{"co":{"cIds":{"226":["2"]}}},"o":{"sIds":["78"]},"t":"sh"},"134":{"i":{"co":{"cIds":{"104":["8"]}}},"o":{"sIds":["27"]},"t":"sh"},"116":{"i":{"co":{"cIds":{"115":["2"]}}},"o":{"sIds":["18"]},"t":"sh"},"225":{"i":{"co":{"cIds":{"36":["7"]}}},"o":{"sIds":["77"]},"t":"sh"},"189":{"i":{"co":{"cIds":{"36":["1"]}}},"o":{"sIds":["59"]},"t":"sh"},"167":{"i":{"co":{"cIds":{"166":["2"]}}},"o":{"sIds":["44"]},"t":"sh"},"229":{"i":{"co":{"cIds":{"96":["10005"]}}},"o":{"sIds":["33"]},"t":"sh"},"205":{"i":{"co":{"cIds":{"36":["6"]}}},"o":{"sIds":["67"]},"t":"sh"},"169":{"i":{"co":{"cIds":{"147":["5"]}}},"o":{"sIds":["45"]},"t":"sh"},"120":{"i":{"co":{"cIds":{"119":["2"]}}},"o":{"sIds":["20"]},"t":"sh"},"193":{"i":{"co":{"cIds":{"36":["2"]}}},"o":{"sIds":["61"]},"t":"sh"},"93":{"i":{"co":{"cIds":{"90":["4"]}}},"o":{"sIds":["9"]},"t":"sh"},"158":{"i":{"co":{"cIds":{"157":["2"]}}},"o":{"sIds":["40"]},"t":"sh"},"142":{"i":{"co":{"cIds":{"104":["7"]}}},"o":{"sIds":["31"]},"t":"sh"},"223":{"i":{"co":{"cIds":{"222":["2"]}}},"o":{"sIds":["76"]},"t":"sh"},"66":{"i":{"co":{"cIds":{"96":["10008"]}}},"o":{"sIds":["57"]},"t":"sh"},"128":{"i":{"co":{"cIds":{"127":["2"]}}},"o":{"sIds":["24"]},"t":"sh"},"40":{"i":{"co":{"cIds":{"96":["10005"]}}},"o":{"sIds":["12"]},"t":"sh"},"110":{"i":{"co":{"cIds":{"104":["2"]}}},"o":{"sIds":["15"]},"t":"sh"},"181":{"i":{"co":{"cIds":{"147":["9"]}}},"o":{"sIds":["51"]},"t":"sh"},"132":{"i":{"co":{"cIds":{"131":["2"]}}},"o":{"sIds":["26"]},"t":"sh"},"201":{"i":{"co":{"cIds":{"36":["3"]}}},"o":{"sIds":["65"]},"t":"sh"},"197":{"i":{"co":{"cIds":{"36":["8"]}}},"o":{"sIds":["63"]},"t":"sh"},"217":{"i":{"co":{"cIds":{"36":["10"]}}},"o":{"sIds":["73"]},"t":"sh"},"177":{"i":{"co":{"cIds":{"147":["8"]}}},"o":{"sIds":["49"]},"t":"sh"},"24":{"i":{"co":{"cIds":{"96":["10004"]}}},"o":{"sIds":["11"]},"t":"sh"},"209":{"i":{"co":{"cIds":{"36":["5"]}}},"o":{"sIds":["69"]},"t":"sh"},"233":{"i":{"co":{"cIds":{"36":["11"]}}},"o":{"sIds":["79"]},"t":"sh"},"152":{"i":{"co":{"cIds":{"147":["2"]}}},"o":{"sIds":["37"]},"t":"sh"},"112":{"i":{"co":{"cIds":{"111":["2"]}}},"o":{"sIds":["16"]},"t":"sh"},"199":{"i":{"co":{"cIds":{"198":["2"]}}},"o":{"sIds":["64"]},"t":"sh"},"144":{"i":{"co":{"cIds":{"143":["2"]}}},"o":{"sIds":["32"]},"t":"sh"},"138":{"i":{"co":{"cIds":{"104":["9"]}}},"o":{"sIds":["29"]},"t":"sh"},"148":{"i":{"co":{"cIds":{"147":["1"]}}},"o":{"sIds":["35"]},"t":"sh"},"65":{"i":{"co":{"cIds":{"96":["10007"]}}},"o":{"sIds":["56"]},"t":"sh"},"213":{"i":{"co":{"cIds":{"36":["4"]}}},"o":{"sIds":["71"]},"t":"sh"},"108":{"i":{"co":{"cIds":{"107":["2"]}}},"o":{"sIds":["14"]},"t":"sh"},"185":{"i":{"co":{"cIds":{"147":["7"]}}},"o":{"sIds":["53"]},"t":"sh"},"219":{"i":{"co":{"cIds":{"218":["2"]}}},"o":{"sIds":["74"]},"t":"sh"},"106":{"i":{"co":{"cIds":{"104":["1"]}}},"o":{"sIds":["13"]},"t":"sh"},"82":{"i":{"co":{"cIds":{"81":["1"]}}},"o":{"sIds":["6"]},"t":"sh"},"126":{"i":{"co":{"cIds":{"104":["5"]}}},"o":{"sIds":["23"]},"t":"sh"},"140":{"i":{"co":{"cIds":{"139":["2"]}}},"o":{"sIds":["30"]},"t":"sh"},"173":{"i":{"co":{"cIds":{"147":["10"]}}},"o":{"sIds":["47"]},"t":"sh"},"221":{"i":{"co":{"cIds":{"36":["9"]}}},"o":{"sIds":["75"]},"t":"sh"},"122":{"i":{"co":{"cIds":{"104":["6"]}}},"o":{"sIds":["21"]},"t":"sh"},"230":{"i":{"co":{"cIds":{"96":["10006"]}}},"o":{"sIds":["55"]},"t":"sh"},"162":{"i":{"co":{"cIds":{"161":["2"]}}},"o":{"sIds":["42"]},"t":"sh"},"191":{"i":{"co":{"cIds":{"190":["2"]}}},"o":{"sIds":["60"]},"t":"sh"},"203":{"i":{"co":{"cIds":{"202":["2"]}}},"o":{"sIds":["66"]},"t":"sh"},"195":{"i":{"co":{"cIds":{"194":["2"]}}},"o":{"sIds":["62"]},"t":"sh"},"156":{"i":{"co":{"cIds":{"147":["3"]}}},"o":{"sIds":["39"]},"t":"sh"},"160":{"i":{"co":{"cIds":{"147":["4"]}}},"o":{"sIds":["41"]},"t":"sh"},"118":{"i":{"co":{"cIds":{"104":["4"]}}},"o":{"sIds":["19"]},"t":"sh"},"187":{"i":{"co":{"cIds":{"186":["2"]}}},"o":{"sIds":["54"]},"t":"sh"},"171":{"i":{"co":{"cIds":{"170":["2"]}}},"o":{"sIds":["46"]},"t":"sh"},"165":{"i":{"co":{"cIds":{"147":["6"]}}},"o":{"sIds":["43"]},"t":"sh"},"235":{"i":{"co":{"cIds":{"81":["2"]}}},"o":{"sIds":["7"]},"t":"sh"},"92":{"i":{"co":{"cIds":{"90":["3"]}}},"o":{"sIds":["5"]},"t":"sh"},"154":{"i":{"co":{"cIds":{"153":["2"]}}},"o":{"sIds":["38"]},"t":"sh"},"215":{"i":{"co":{"cIds":{"214":["2"]}}},"o":{"sIds":["72"]},"t":"sh"},"183":{"i":{"co":{"cIds":{"182":["2"]}}},"o":{"sIds":["52"]},"t":"sh"},"97":{"i":{"co":{"cIds":{"79":["1"]}}},"o":{"sIds":["4"]},"t":"sh"},"114":{"i":{"co":{"cIds":{"104":["3"]}}},"o":{"sIds":["17"]},"t":"sh"},"130":{"i":{"co":{"cIds":{"104":["10"]}}},"o":{"sIds":["25"]},"t":"sh"},"179":{"i":{"co":{"cIds":{"178":["2"]}}},"o":{"sIds":["50"]},"t":"sh"},"207":{"i":{"co":{"cIds":{"206":["2"]}}},"o":{"sIds":["68"]},"t":"sh"},"41":{"i":{"co":{"cIds":{"96":["10006"]}}},"o":{"sIds":["34"]},"t":"sh"},"211":{"i":{"co":{"cIds":{"210":["2"]}}},"o":{"sIds":["70"]},"t":"sh"},"150":{"i":{"co":{"cIds":{"149":["2"]}}},"o":{"sIds":["36"]},"t":"sh"},"91":{"i":{"co":{"cIds":{"90":["2"]}}},"o":{"sIds":["3"]},"t":"sh"},"85":{"i":{"co":{"cIds":{"81":["2"]}}},"o":{"sIds":["8"]},"t":"sh"},"28":{"i":{"co":{"cIds":{"96":["10009"]}}},"o":{"sIds":["58"]},"t":"sh"},"136":{"i":{"co":{"cIds":{"135":["2"]}}},"o":{"sIds":["28"]},"t":"sh"}},"sections":{"18":{"name":"scRNAseq No","conditions":["116"]},"52":{"name":"Spectral Flow No","conditions":["183"]},"28":{"name":"CyToF No","conditions":["136"]},"45":{"name":"Aabs Information","conditions":["169"]},"34":{"name":"Tier 3 Data Request","conditions":["41"]},"67":{"name":"Microbiome Information","conditions":["205"]},"12":{"name":"Tier 2 Data Request","conditions":["40"]},"66":{"name":"TCR-BCR No","conditions":["203"]},"51":{"name":"Spectral Flow Information","conditions":["181"]},"8":{"name":"Pending Grant Other Source","conditions":["85"]},"73":{"name":"CyToF Information","conditions":["217"]},"78":{"name":"HCQ No","conditions":["227"]},"19":{"name":"TCR-BCR Sequencing Information","conditions":["118"]},"23":{"name":"Aabs Information","conditions":["126"]},"62":{"name":"Bulk RNAseq No","conditions":["195"]},"4":{"name":"Current LRA Grant Mechanism","conditions":["97"]},"77":{"name":"HCQ Levels Information","conditions":["225"]},"40":{"name":"scRNAseq No","conditions":["158"]},"15":{"name":"Bulk RNAseq Information","conditions":["110"]},"11":{"name":"Tier 1 Data Request","conditions":["24"]},"9":{"name":"No Funding","conditions":["93"]},"44":{"name":"Microbial Metagenomics No","conditions":["167"]},"33":{"name":"Additional Information","conditions":["229"]},"22":{"name":"Microbial Metagenomics No","conditions":["124"]},"56":{"name":"Electronic Medical record data","conditions":["65"]},"55":{"name":"Additional Information","conditions":["230"]},"26":{"name":"Proteomics No","conditions":["132"]},"50":{"name":"CyToF No","conditions":["179"]},"37":{"name":"Bulk RNAseq Information","conditions":["152"]},"68":{"name":"Microbial Metagenomics No","conditions":["207"]},"61":{"name":"Bulk RNAseq Information","conditions":["193"]},"13":{"name":"WGS Information","conditions":["106"]},"46":{"name":"Aabs No","conditions":["171"]},"24":{"name":"Aabs No","conditions":["128"]},"35":{"name":"WGS Information","conditions":["148"]},"16":{"name":"Bulk RNAseq No","conditions":["112"]},"79":{"name":"Other Assay(s)","conditions":["233"]},"5":{"name":"Pending Grant Award","conditions":["92"]},"72":{"name":"Proteomics No","conditions":["215"]},"10":{"conditions":[]},"59":{"name":"WGS Information","conditions":["189"]},"48":{"name":"Proteomics No","conditions":["175"]},"21":{"name":"Microbiome Information","conditions":["122"]},"76":{"name":"Spectral Flow No","conditions":["223"]},"54":{"name":"HCQ No","conditions":["187"]},"43":{"name":"Microbiome Information","conditions":["165"]},"65":{"name":"TCR-BCR Sequencing Information","conditions":["201"]},"71":{"name":"Proteomics Information","conditions":["213"]},"57":{"name":"data services","conditions":["66"]},"32":{"name":"HCQ No","conditions":["144"]},"49":{"name":"CyToF Information","conditions":["177"]},"6":{"name":"Pending Grant LRA Mech","conditions":["82"]},"36":{"name":"WGS No","conditions":["150"]},"1":{"conditions":[]},"39":{"name":"scRNAseq Information","conditions":["156"]},"17":{"name":"scRNAseq Information","conditions":["114"]},"25":{"name":"Proteomics Information","conditions":["130"]},"60":{"name":"WGS No","conditions":["191"]},"14":{"name":"WGS No","conditions":["108"]},"47":{"name":"Proteomics Information","conditions":["173"]},"31":{"name":"HCQ Levels Information","conditions":["142"]},"69":{"name":"Aabs Information","conditions":["209"]},"58":{"name":"Biosample Request","conditions":["28"]},"64":{"name":"scRNAseq No","conditions":["199"]},"53":{"name":"HCQ Levels Information","conditions":["185"]},"42":{"name":"TCR-BCR No","conditions":["162"]},"75":{"name":"Spectral Flow Information","conditions":["221"]},"20":{"name":"TCR-BCR No","conditions":["120"]},"27":{"name":"CyToF Information","conditions":["134"]},"70":{"name":"Aabs No","conditions":["211"]},"2":{"name":"Academia Researchers","conditions":[]},"38":{"name":"Bulk RNAseq No","conditions":["154"]},"30":{"name":"Spectral Flow No","conditions":["140"]},"7":{"name":"Other Funding Source","conditions":["235"]},"29":{"name":"Spectral Flow Information","conditions":["138"]},"41":{"name":"TCR-BCR Sequencing Information","conditions":["160"]},"63":{"name":"scRNAseq Information","conditions":["197"]},"3":{"name":"Current Grant Award","conditions":["91"]},"74":{"name":"CyToF No","conditions":["219"]}},"questions":{"121":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the TCR-BCR Sequencing methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"115":{"type":"cd","label":"scRNAseq Methodology","description":"We will be performing scRNAseq on unsorted and unstimulated PBMCs via: 10X Genomics Chromium X series, sequenced on an Illumina NovaSeq X plus or equivalent, with a capture target of 3,000 cells per sample and a depth of at least 50,000 reads per cell. Would this sequencing be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"198":{"type":"cd","label":"scRNAseq Methodology","description":"We will be performing scRNAseq on unsorted and unstimulated PBMCs via: 10X Genomics Chromium X series, sequenced on an Illumina NovaSeq X plus or equivalent, with a capture target of 3,000 cells per sample and a depth of at least 50,000 reads per cell. Would this sequencing be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"45":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"8","label":"21 Month Visit","other":false},{"id":"9","label":"24 Month Visit","other":false},{"id":"10","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"98":{"type":"cd","label":"Lupus Research Alliance Grant Mechanism","description":"Select only one","validation":{"rq":true},"choices":[{"id":"1","label":"Cross Collaborative GTSA Supplement (CCGS)","other":false},{"id":"2","label":"Common Mechanisms in Autoimmunity Insight Award (CMIA)","other":false},{"id":"3","label":"Empowering Lupus Research-Administrative Supplement (ELRAS)","other":false},{"id":"4","label":"Empowering Lupus Research-Career Development Award (ELR-CDA)","other":false},{"id":"5","label":"Empowering Lupus Research-Post-Doctoral Award (ELR-PDA)","other":false},{"id":"6","label":"Rheumatology Research Foundation-Scientist Development Award (RRF-SDA)","other":false},{"id":"7","label":"Engineered Cell Therapies (ECT)","other":false},{"id":"8","label":"Global Team Science Award (GTSA)","other":false},{"id":"9","label":"Lupus Innovation Award (LIA)","other":false},{"id":"10","label":"Mechanistic Clinical Award (MCA)","other":false},{"id":"11","label":"Translational Bridge Award (TBA)","other":false}],"questionKey":""},"113":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Bulk RNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"67":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding cases and timepoints.","validation":{"rq":false},"choices":[],"questionKey":""},"153":{"type":"cd","label":"Bulk RNAseq Methodology","description":"We will we performing bulk RNAseq stemming from PaxGene tubes, and it will be performed using the NEBNext-Ultra II RNA library preparation kit, and then sequenced to ~20M reads/sample or 6Gb/sample, for differential gene expression analysis. Sequencing will be performed on the NovaSeq X Plus platform at a 2x150bp configuration. In your experience, would this protocol be adequate to pick up on expression levels of your gene(s) of interest?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"182":{"type":"cd","label":"Spectral Flow Methodology","description":"We will be performing Spectral Flow Cytometry on unsorted and unstimulated PBMCs via: The Cytek Aurora, which has a 5 laser configuration, 40 colors, and 67 parameters. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"147":{"type":"cl","label":"Type of Biomarker Data","description":"Select the requested analysis below (select all that apply).","validation":{"rq":true,"mns":1},"choices":[{"id":"1","label":"Whole Genome Sequencing","other":false},{"id":"2","label":"Bulk RNA Sequencing","other":false},{"id":"3","label":"Single-Cell RNA Sequencing","other":false},{"id":"4","label":"TCR and/or BCR Sequencing","other":false},{"id":"6","label":"Microbial Metagenomics","other":false},{"id":"5","label":"Auto-Antibodies (Lupus-Associated)","other":false},{"id":"10","label":"Proteomics","other":false},{"id":"8","label":"CyToF","other":false},{"id":"9","label":"Spectral Flow Cytometry","other":false},{"id":"7","label":"Hydroxychloroquine Medication Levels","other":false},{"id":"11","label":"DxTerity IFN-1 MIP Assay","other":false}],"questionKey":""},"51":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"8","label":"21 Month Visit","other":false},{"id":"9","label":"24 Month Visit","other":false},{"id":"10","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"216":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Proteomics methodology above.","description":"Please include any proteins not found in the Olink platform mentioned above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"89":{"type":"rt","label":"Please explain further how this research will be financially supported.","description":"","validation":{"rq":false},"choices":[],"questionKey":""},"84":{"type":"da","label":"Date of Anticipated LRA Funding Source","description":"Please select a date","validation":{"rq":true},"choices":[],"questionKey":""},"164":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the TCR-BCR Sequencing methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"170":{"type":"cd","label":"Aabs Methodology","description":"We will be measuring lupus-associated auto-antibodies (Aabs): ANA, C1q, B2GP1, KIF20B, NMDAR2, Cardiolipin, dsDNA, SSB/La, SSA/Ro60, TRIM21/Ro52, RNP, Sm, Scl-70, Centromere, Ribosomal P, Jo-1, DFS70. Would those datasets be sufficient for your Aab needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"19":{"type":"ts","label":"Company/Institution","description":"Company or institution name.","validation":{"rq":true},"choices":[],"questionKey":""},"62":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"8","label":"21 Month Visit","other":false},{"id":"9","label":"24 Month Visit","other":false},{"id":"10","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"135":{"type":"cd","label":"CyToF Methodology","description":"We will be performing CyToF on unsorted and unstimulated PBMCs via: The CyTOF XT, set to acquire 300,000 events. The current assay can easily be made customizable with up to 47 parameters per sample. The final panel of choice can include surface, intracellular, and even intra nuclear markers all within the same tube. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"15":{"type":"cd","label":"Company/Institution Type","description":"Type of Institution.","validation":{"rq":true},"jiraField":"customfield_10351","questionKey":""},"104":{"type":"cl","label":"Type of Biomarker Data","description":"Select the requested analysis below (select all that apply).","validation":{"rq":true,"mns":1},"choices":[{"id":"1","label":"Whole Genome Sequencing","other":false},{"id":"2","label":"Bulk RNA Sequencing","other":false},{"id":"3","label":"Single-Cell RNA Sequencing","other":false},{"id":"4","label":"TCR and/or BCR Sequencing","other":false},{"id":"6","label":"Microbial Metagenomics","other":false},{"id":"5","label":"Auto-Antibodies (Lupus-Associated)","other":false},{"id":"10","label":"Proteomics","other":false},{"id":"8","label":"CyToF","other":false},{"id":"9","label":"Spectral Flow Cytometry","other":false},{"id":"7","label":"Hydroxychloroquine Medication Levels","other":false},{"id":"11","label":"DxTerity IFN-1 MIP Assay","other":false}],"questionKey":""},"90":{"type":"cl","label":"Funding Source","description":"Select your funding source. You can select more than one.","validation":{"rq":true},"choices":[{"id":"1","label":"Institutional/Organizational Funds","other":false},{"id":"2","label":"Current Grant Award","other":false},{"id":"3","label":"Pending Grant Award","other":false},{"id":"4","label":"No Funding","other":false}],"questionKey":""},"141":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Spectral Flow Cytometry methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"139":{"type":"cd","label":"Spectral Flow Methodology","description":"We will be performing Spectral Flow Cytometry on unsorted and unstimulated PBMCs via: The Cytek Aurora, which has a 5 laser configuration, 40 colors, and 67 parameters. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"33":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"117":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the scRNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"186":{"type":"cd","label":"HCQ Methodology","description":"We will be measuring hydroxychloroquine (HCQ) levels in participants currently taking the medication via: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS), which provides the concentration of HCQ measured in nanograms/milliliter. Would this be adequate for your project’s needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"55":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"8","label":"21 Month Visit","other":false},{"id":"9","label":"24 Month Visit","other":false},{"id":"10","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"212":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Auto-Antibody methodology above.","description":"Please include any Aabs not found in the list above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"50":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"123":{"type":"cd","label":"Microbial Metagenomics Methodology","description":"We will be performing microbial metagenomics on stool samples where gDNA is extracted using an optimized and validated extraction method (QIAGEN Powersoil Pro) and sequenced on an Illumina NovaSeq X platform or Element AVITI platform (or equivalent at time of processing) on a 2X150bp specification. Would those datasets be sufficient for your microbiome needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"174":{"type":"cd","label":"Proteomics Methodology","description":"We will have proteomics data on plasma, and we will be using the Olink Explore HT assay (over 6,000 proteins). Would those datasets be sufficient for your proteomics needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"68":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding cases, timepoints, or assays","validation":{"rq":false,"mxw":100},"choices":[],"questionKey":""},"26":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"224":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Spectral Flow Cytometry methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"166":{"type":"cd","label":"Microbial Metagenomics Methodology","description":"We will be performing microbial metagenomics on stool samples where gDNA is extracted using an optimized and validated extraction method (QIAGEN Powersoil Pro) and sequenced on an Illumina NovaSeq X platform or Element AVITI platform (or equivalent at time of processing) on a 2X150bp specification. Would those datasets be sufficient for your microbiome needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"61":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"107":{"type":"cd","label":"WGS Methodology","description":"We will have WGS performed for all individuals in our study, and all libraries will be dual-barcoded and sequenced with 150bp paired-end reads on the Illumina NovaSeq X Plus platform with at least 30X depth. In your experience, would this protocol be adequate to pick up on the mutations you are interested in?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"46":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"206":{"type":"cd","label":"Microbial Metagenomics Methodology","description":"We will be performing microbial metagenomics on stool samples where gDNA is extracted using an optimized and validated extraction method (QIAGEN Powersoil Pro) and sequenced on an Illumina NovaSeq X platform or Element AVITI platform (or equivalent at time of processing) on a 2X150bp specification. Would those datasets be sufficient for your microbiome needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"155":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Bulk RNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"83":{"type":"cd","label":"Lupus Research Alliance Grant Mechanism","description":"Select only one","validation":{"rq":true},"jiraField":"customfield_10451","questionKey":""},"35":{"type":"ts","label":"Sample Volume or Cell Number per Timepoint","description":"Enter the sample volume or cell number required","validation":{"rq":true},"choices":[],"questionKey":""},"192":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the WGS methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"79":{"type":"cl","label":"Current Grant Source","description":"You can select more than one","validation":{"rq":true},"choices":[{"id":"1","label":"Lupus Research Alliance","other":false},{"id":"0","label":"Other...","other":true}],"questionKey":""},"5":{"type":"te","label":"Email","description":"What's your email address?","validation":{"rq":true},"choices":[],"questionKey":""},"159":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the scRNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"59":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding your request","validation":{"rq":false},"choices":[],"questionKey":""},"237":{"type":"rt","label":"Please describe the funding source for which your grant is pending","description":"","validation":{"rq":true},"choices":[],"questionKey":""},"196":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Bulk RNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"48":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"10","label":"21 Month Visit","other":false},{"id":"8","label":"24 Month Visit","other":false},{"id":"9","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"21":{"type":"rt","label":"Research Abstract","description":"Please give a description of your research project and how the DREAM can help.","validation":{"rq":true,"mxw":1000},"jiraField":"description","questionKey":""},"228":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the HCQ medication level methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"188":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the HCQ medication level methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"127":{"type":"cd","label":"Aabs Methodology","description":"We will be measuring lupus-associated auto-antibodies (Aabs): ANA, C1q, B2GP1, KIF20B, NMDAR2, Cardiolipin, dsDNA, SSB/La, SSA/Ro60, TRIM21/Ro52, RNP, Sm, Scl-70, Centromere, Ribosomal P, Jo-1, DFS70. Would those datasets be sufficient for your Aab needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"57":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding cases, timepoints, or assays","validation":{"rq":false,"mxw":100},"choices":[],"questionKey":""},"202":{"type":"cd","label":"TCR-BCR Sequencing Methodology","description":"We will be performing a 7-chain TCR and BCR assay using a multiplex PCR assay that simultaneously captures the immune repertoire of both TCRs and BCRs in the same reaction (T-cell receptor α, β, δ, ɣ, and B-cell Ig κ and λ; all isotypes). The resultant, error corrected, and mapped immune adaptome data include the RNA frequency or expression of each clonotype or unique V-J-uCDR3 (uCDR3) expression inclusive of V-, (D-), J- gene segment annotation and frequency, and several sample related diversity metrics including D50, diversity index, shannon entropy, and Pielou’s evenness. Sequencing is performed on the Illumina NextSeq P2 (600-cycle, XLEAP) in paired end read (PER) format. Would those datasets be sufficient for your TCR/BCR needs? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"234":{"type":"rt","label":"Other Intended Analyses","description":"Please describe any other intended analyses for the biosamples.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"137":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the CyToF methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"49":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"36":{"type":"cl","label":"Intended Analyses","description":"Select the intended analyses below (select all that apply). If \"Other\" is chosen, please use the \"Notes\" field to elaborate on the desired analyses.","validation":{"rq":true},"choices":[{"id":"1","label":"Whole Genome Sequencing","other":false},{"id":"2","label":"Bulk RNA Sequencing","other":false},{"id":"8","label":"Single-Cell RNA Sequencing","other":false},{"id":"3","label":"TCR and/or BCR Sequencing","other":false},{"id":"6","label":"Microbial Metagenomics","other":false},{"id":"5","label":"Auto-Antibodies (Lupus-Associated)","other":false},{"id":"4","label":"Proteomics","other":false},{"id":"10","label":"CyToF","other":false},{"id":"9","label":"Spectral Flow Cytometry","other":false},{"id":"7","label":"Hydroxychloroquine Medication Levels","other":false},{"id":"11","label":"Other Assay(s)","other":false}],"questionKey":""},"1":{"type":"ts","label":"Name","description":"What's your name?","validation":{"rq":true},"choices":[],"questionKey":""},"180":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the CyToF methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"25":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"60":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"208":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Microbial Metagenomics methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"133":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Proteomics methodology above.","description":"Please include any proteins not found in the Olink platform mentioned above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"47":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"111":{"type":"cd","label":"Bulk RNAseq Methodology","description":"We will we performing bulk RNAseq stemming from PaxGene tubes, and it will be performed using the NEBNext-Ultra II RNA library preparation kit, and then sequenced to ~20M reads/sample or 6Gb/sample, for differential gene expression analysis. Sequencing will be performed on the NovaSeq X Plus platform at a 2x150bp configuration. In your experience, would this protocol be adequate to pick up on expression levels of your gene(s) of interest?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"151":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the WGS methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"95":{"type":"cd","label":"Technical Capabilities","description":"What are the technical capabilities of your team?","validation":{"rq":true},"choices":[{"id":"1","label":"No Code","other":false},{"id":"2","label":"Low Code (SQL, simple scripts)","other":false},{"id":"3","label":"Medium Code (Jupyter Notebook, Rstudio)","other":false},{"id":"4","label":"High Code (Nextflow, R, Python)","other":false},{"id":"0","label":"Other...","other":true}],"questionKey":""},"96":{"type":"cl","label":"Type of Request","description":"What kind of request do you want to make? Select all that apply.","validation":{"rq":true},"jiraField":"components","questionKey":""},"69":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding cases and timepoints","validation":{"rq":false,"mxw":100},"choices":[],"questionKey":""},"190":{"type":"cd","label":"WGS Methodology","description":"We will have WGS performed for all individuals in our study, and all libraries will be dual-barcoded and sequenced with 150bp paired-end reads on the Illumina NovaSeq X Plus platform with at least 30X depth. In your experience, would this protocol be adequate to pick up on the mutations you are interested in?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"145":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the HCQ medication level methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"184":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Spectral Flow Cytometry methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"64":{"type":"rt","label":"Data Service Request Instructions","description":"Please enter more detailed instructions regarding your request","validation":{"rq":false},"choices":[],"questionKey":""},"214":{"type":"cd","label":"Proteomics Methodology","description":"We will have proteomics data on plasma, and we will be using the Olink Explore HT assay (over 6,000 proteins). Would those datasets be sufficient for your proteomics needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"109":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the WGS methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"149":{"type":"cd","label":"WGS Methodology","description":"We will have WGS performed for all individuals in our study, and all libraries will be dual-barcoded and sequenced with 150bp paired-end reads on the Illumina NovaSeq X Plus platform with at least 30X depth. In your experience, would this protocol be adequate to pick up on the mutations you are interested in?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"20":{"type":"ts","label":"Project Title","description":"Name of your project.","validation":{"rq":true,"mxw":100},"jiraField":"summary","questionKey":""},"178":{"type":"cd","label":"CyToF Methodology","description":"We will be performing CyToF on unsorted and unstimulated PBMCs via: The CyTOF XT, set to acquire 300,000 events. The current assay can easily be made customizable with up to 47 per sample. The final panel of choice can include surface, intracellular, and even intra nuclear markers all within the same tube. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"210":{"type":"cd","label":"Aabs Methodology","description":"We will be measuring lupus-associated auto-antibodies (Aabs): ANA, C1q, B2GP1, KIF20B, NMDAR2, Cardiolipin, dsDNA, SSB/La, SSA/Ro60, TRIM21/Ro52, RNP, Sm, Scl-70, Centromere, Ribosomal P, Jo-1, DFS70. Would those datasets be sufficient for your Aab needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"86":{"type":"da","label":"Date of Anticipated Other Funding Source","description":"Please select a date","validation":{"rq":true},"choices":[],"questionKey":""},"38":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"81":{"type":"cl","label":"Pending Grant Source","description":"You can select more than one","validation":{"rq":true},"choices":[{"id":"1","label":"Lupus Research Alliance","other":false},{"id":"2","label":"Other Funding Source","other":false}],"questionKey":""},"125":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Microbial Metagenomics methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"18":{"type":"ts","label":"Job Title","description":"What's your job title?","validation":{"rq":false},"choices":[],"questionKey":""},"194":{"type":"cd","label":"Bulk RNAseq Methodology","description":"We will we performing bulk RNAseq stemming from PaxGene tubes, and it will be performed using the NEBNext-Ultra II RNA library preparation kit, and then sequenced to ~20M reads/sample or 6Gb/sample, for differential gene expression analysis. Sequencing will be performed on the NovaSeq X Plus platform at a 2x150bp configuration. In your experience, would this protocol be adequate to pick up on expression levels of your gene(s) of interest?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"220":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the CyToF methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"7":{"type":"ts","label":"Phone","description":"What's your phone number?","validation":{"rq":false},"choices":[],"questionKey":""},"143":{"type":"cd","label":"HCQ Methodology","description":"We will be measuring hydroxychloroquine (HCQ) levels in participants currently taking the medication via: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS), which provides the concentration of HCQ measured in nanograms/milliliter. Would this be adequate for your project’s needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"218":{"type":"cd","label":"CyToF Methodology","description":"We will be performing CyToF on unsorted and unstimulated PBMCs via: The CyTOF XT, set to acquire 300,000 events. The current assay can easily be made customizable with up to 47 per sample. The final panel of choice can include surface, intracellular, and even intra nuclear markers all within the same tube. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"222":{"type":"cd","label":"Spectral Flow Methodology","description":"We will be performing Spectral Flow Cytometry on unsorted and unstimulated PBMCs via: The Cytek Aurora, which has a 5 laser configuration, 40 colors, and 67 parameters. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"129":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Auto-Antibody methodology above.","description":"Please include any Aabs not found in the list above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"29":{"type":"cl","label":"Sample Type(s)","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"2","label":"Stool","other":false},{"id":"3","label":"PBMC","other":false},{"id":"4","label":"Serum","other":false},{"id":"5","label":"Plasma","other":false},{"id":"6","label":"Urine (whole)","other":false},{"id":"7","label":"Urine (cells)","other":false},{"id":"8","label":"Urine (supernatant)","other":false},{"id":"9","label":"RNA","other":false},{"id":"10","label":"gDNA","other":false},{"id":"11","label":"Saliva","other":false}],"questionKey":""},"168":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Microbial Metagenomics methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"204":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the TCR-BCR Sequencing methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"226":{"type":"cd","label":"HCQ Methodology","description":"We will be measuring hydroxychloroquine (HCQ) levels in participants currently taking the medication via: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS), which provides the concentration of HCQ measured in nanograms/milliliter. Would this be adequate for your project’s needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"52":{"type":"cs","label":"Preferred Communication ","description":"What's the best way to reach you?","validation":{"rq":false},"choices":[{"id":"1","label":"Email","other":false},{"id":"2","label":"Phone","other":false}],"questionKey":""},"172":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Auto-Antibody methodology above.","description":"Please include any Aabs not found in the list above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"131":{"type":"cd","label":"Proteomics Methodology","description":"We will have proteomics data on plasma, and we will be using the Olink Explore HT assay (over 6,000 proteins). Would those datasets be sufficient for your proteomics needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"200":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the scRNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"119":{"type":"cd","label":"TCR-BCR Sequencing Methodology","description":"We will be performing a 7-chain TCR and BCR assay using a multiplex PCR assay that simultaneously captures the immune repertoire of both TCRs and BCRs in the same reaction (T-cell receptor α, β, δ, ɣ, and B-cell Ig κ and λ; all isotypes). The resultant, error corrected, and mapped immune adaptome data include the RNA frequency or expression of each clonotype or unique V-J-uCDR3 (uCDR3) expression inclusive of V-, (D-), J- gene segment annotation and frequency, and several sample related diversity metrics including D50, diversity index, Shannon entropy, and Pielou’s evenness. Sequencing is performed on the Illumina NextSeq P2 (600-cycle, XLEAP) in paired end read (PER) format. Would those datasets be sufficient for your TCR/BCR needs? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"161":{"type":"cd","label":"TCR-BCR Sequencing Methodology","description":"We will be performing a 7-chain TCR and BCR assay using a multiplex PCR assay that simultaneously captures the immune repertoire of both TCRs and BCRs in the same reaction (T-cell receptor α, β, δ, ɣ, and B-cell Ig κ and λ; all isotypes). The resultant, error corrected, and mapped immune adaptome data include the RNA frequency or expression of each clonotype or unique V-J-uCDR3 (uCDR3) expression inclusive of V-, (D-), J- gene segment annotation and frequency, and several sample related diversity metrics including D50, diversity index, shannon entropy, and Pielou’s evenness. Sequencing is performed on the Illumina NextSeq P2 (600-cycle, XLEAP) in paired end read (PER) format. Would those datasets be sufficient for your TCR/BCR needs? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"157":{"type":"cd","label":"scRNAseq Methodology","description":"We will be performing scRNAseq on unsorted and unstimulated PBMCs via: 10X Genomics Chromium X series, sequenced on an Illumina NovaSeq X plus or equivalent, with a capture target of 3,000 cells per sample and a depth of at least 50,000 reads per cell. Would this sequencing be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"176":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Proteomics methodology above.","description":"Please include any proteins not found in the Olink platform mentioned above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""}}},"uuid":"ce7605d7-5892-4597-838a-8cbc2367fcac"},"proforma":{"formExists":true,"formValid":true,"formTemplateData":{"id":7805372048849154,"updated":"2026-05-19T19:45:02.141247164Z","publish":{"jira":{"submitOnCreate":true,"validateOnCreate":true},"portal":{"portalRequestTypeIds":[9],"submitOnCreate":true,"validateOnCreate":true}},"design":{"settings":{"templateId":7805372048849154,"name":"Resource Request V5","submit":{"lock":false,"pdf":true},"templateFormUuid":"ce7605d7-5892-4597-838a-8cbc2367fcac"},"layout":[{"version":1,"type":"doc","content":[{"type":"paragraph","content":[]},{"type":"paragraph","content":[]},{"type":"heading","attrs":{"level":2,"localId":"1b226e20-4ba9-496e-8e63-7b62266bd5bc"},"content":[{"type":"text","text":"Access and Resource Request","marks":[{"type":"strong"}]}]},{"type":"heading","attrs":{"level":2,"localId":"58e6c50c-bec3-44a6-a18c-54002548c345"},"content":[{"type":"text","text":"Contact Information","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"42287ce5-0daa-42cf-8d6d-6b9576c92bd6"},"content":[{"type":"text","text":"Let’s start with the basics."}]}]},{"version":1,"type":"doc","content":[{"type":"paragraph","content":[]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":50},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":1},"layout":"default","localId":"18afaf6e-8cbd-42fb-bed1-4229656b8845"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":18},"layout":"default","localId":"0591354d-caf2-475b-b415-81ba8bb4995c"}}]},{"type":"layoutColumn","attrs":{"width":50},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":5},"layout":"default","localId":"e3101f42-6448-490b-b54f-a08ecf04f77b"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":7},"layout":"default","localId":"60f46de1-c8c8-4d6a-acfa-25a289b4f712"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":52},"layout":"default","localId":"ea4095dd-a1e5-4725-9ec8-21d9c0f31e40"}}]}]},{"type":"heading","attrs":{"level":2,"localId":"ef62dea6-ed6f-4114-80c1-49f7eae293ce"},"content":[{"type":"text","text":"Organization Information","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"561c21ce-4ff6-4a78-8622-20d6f3b8f32e"},"content":[{"type":"text","text":"Where are you from and what are your technical capabilities?"}]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":50},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":19},"layout":"default","localId":"9a851fee-957e-48ab-83f0-b87812be5e2f"}},{"type":"paragraph","content":[]}]},{"type":"layoutColumn","attrs":{"width":50},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":15},"layout":"default","localId":"5dbe1a8b-a390-4eac-ba29-75540f52e955"}}]}]},{"type":"paragraph","content":[]},{"type":"paragraph","content":[]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":95},"layout":"default","localId":"d873e962-8ce8-4207-9f7e-1f43c8c10484"}},{"type":"paragraph","content":[]}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"d3d35951-9b6d-4466-81fe-7012509edcff"},"content":[{"type":"text","text":"Funding","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"370853ea-22f4-413a-aedb-55480b50f125"},"content":[{"type":"text","text":"Enter the following information on funding."}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":90},"layout":"default","localId":"d50e0e22-b554-43b7-b0fb-b5c1dd54dbd8"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":79},"layout":"default","localId":"56735811-7f07-490c-95f6-74b71a7913bd"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":98},"layout":"default","localId":"f1178cc6-355c-4cef-87cb-197bc9b754b6"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":81},"layout":"default","localId":"1e0f8963-9b7a-4501-bca1-070c2fb3a61d"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":83},"layout":"default","localId":"634abb61-67de-4fde-8a7e-241cb3ae773c"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":84},"layout":"default","localId":"4366e8db-d996-4ba4-b3e0-41883f4b5259"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":237},"layout":"default","localId":"ab0e4018-bc10-4136-a2f3-191a3ef2acd5"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":86},"layout":"default","localId":"1ba4eb0d-8afc-44be-a2c1-23890f9be205"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":89},"layout":"default","localId":"9880e7d2-b449-4c4b-aeab-f33c9a477eb7"}},{"type":"paragraph","content":[]}]},{"version":1,"type":"doc","content":[{"type":"paragraph","content":[]},{"type":"heading","attrs":{"level":2,"localId":"3d6d8459-eb48-419c-a4f4-995d9c5d974b"},"content":[{"type":"text","text":"Project Information","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"a729c363-1ff2-4a4b-ac2d-60814360c68e"},"content":[{"type":"text","text":"What type of lupus research are you performing?"}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":20},"layout":"default","localId":"180acefa-d4e8-4a3a-92f5-962bdee231eb"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":21},"layout":"default","localId":"94547d37-2b37-4349-8cae-fe540cd8132d"}},{"type":"paragraph","content":[]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":96},"layout":"default","localId":"41e378f9-5c25-4aad-84ca-46881144b562"}},{"type":"paragraph","content":[]}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"910bc439-f4c1-4e6f-8026-284b0f5f5a97"},"content":[{"type":"text","text":"Tier 1: Clinical and Real-World Data (CRWD)","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"51ffa63e-a0a8-439f-84e8-78553193ce9d"},"content":[{"type":"text","text":"Tier 1 Data includes all clinician- and patient-reported outcome data from samples associated with the parameters below."}]},{"type":"paragraph","content":[]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":25},"layout":"default","localId":"c9ebf629-87ce-48d7-8328-1474c97d5c74"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":26},"layout":"default","localId":"2a497f04-fef5-4a80-9af4-d27df1f630bb"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":45},"layout":"default","localId":"b0985f71-beeb-45dd-9e38-9133cc30710e"}},{"type":"paragraph","content":[]}]}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":67},"layout":"default","localId":"ab2f556e-60d0-4978-ac54-4dcc76bcab5c"}}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"b1734bc4-c13a-47c5-a4c9-e270c7faae02"},"content":[{"type":"text","text":"Tier 2: Biomarker Data (Scientific Data)","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"0e569c88-bc9a-4b62-94a1-4d479112f112"},"content":[{"type":"text","text":"Tier 2 Data includes scientific (testing results) from samples associated with the parameters below."}]},{"type":"paragraph","content":[]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":46},"layout":"default","localId":"02ec0571-7407-4f65-88f2-354e2569c679"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":47},"layout":"default","localId":"29df47cc-b1d8-4371-b088-8b492f756189"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":48},"layout":"default","localId":"0bbaa0fe-a638-472d-b202-e021d440c4c8"}}]}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":104},"layout":"default","localId":"b91efe26-7c3f-4f45-b99a-fe6c7865becc"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":107},"layout":"default","localId":"49420e6e-10c0-491e-9c35-9ca0fea8560a"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":109},"layout":"default","localId":"d83dd6a2-a614-42aa-bd27-04950a48747c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":111},"layout":"default","localId":"68ba189f-ded2-4686-b2d7-d9bef9cb945c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":113},"layout":"default","localId":"543bb0d6-24c9-45ff-b834-f63728f6b894"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":115},"layout":"default","localId":"869e43f2-638c-47fb-bcf6-b4ae7eb26526"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":117},"layout":"default","localId":"8d9b8dcf-a84f-4536-8636-26fee9c6ab0c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":119},"layout":"default","localId":"5f38c5c9-7f53-4d6f-ba97-e11b71cd39a4"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":121},"layout":"default","localId":"7f4c96a3-f914-4f19-ae68-a34276385fd8"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":123},"layout":"default","localId":"0102887a-dfbe-4398-b528-59b1978c4f03"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":125},"layout":"default","localId":"081536ac-0729-45c9-bb2a-35e26f780d05"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":127},"layout":"default","localId":"8aa9803d-5596-4859-b633-a168e27e55de"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":129},"layout":"default","localId":"97b1e421-a262-466a-8ccb-c53bea658c89"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":131},"layout":"default","localId":"1c8cbd5a-cbcf-486c-8a6a-86984db7df96"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":133},"layout":"default","localId":"4d039264-aff0-4b4b-9106-63853147b3dd"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":135},"layout":"default","localId":"d644760c-fe86-49be-9011-208656565935"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":137},"layout":"default","localId":"0147a8e0-43de-451f-8e9e-236bd6fb8584"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":139},"layout":"default","localId":"7ea24e60-a411-4fa9-8b97-9ad725448349"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":141},"layout":"default","localId":"cd124524-f881-4e70-923d-a0c2eb36bb3a"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":143},"layout":"default","localId":"3a4a3f46-0576-42b2-87c1-7b9a06678605"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":145},"layout":"default","localId":"7a46e1ce-744c-44ec-8476-f6929627945f"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":57},"layout":"default","localId":"7d57aa65-2a7b-4a0b-a504-aac4de71034d"}}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"e398cb8d-798e-44e1-95aa-51f15a2bca44"},"content":[{"type":"text","text":"Tier 3: Clinical/Real-World Data & Biomarker Data","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"0ef37cda-3b08-4e38-8dfe-3bb727a37197"},"content":[{"type":"text","text":"Tier 3 Data includes all clinician- and patient-reported outcome data and all scientific data (testing results) from samples associated with the parameters below."}]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":49},"layout":"default","localId":"ba95874f-8498-45e2-8e70-e1d14ce47ca8"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":50},"layout":"default","localId":"5972264e-c8ad-4d4a-9018-ca51fdd0f99e"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":51},"layout":"default","localId":"aae93c1c-75a2-40eb-8e30-447fdd666546"}}]}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":147},"layout":"default","localId":"1b86882e-fa61-4de3-b98c-ed112effad38"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":149},"layout":"default","localId":"b17655d5-a498-4e3f-b668-77ab93c421a6"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":151},"layout":"default","localId":"497a93c9-c3e8-4d02-9c4b-7e33dbcfc54e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":153},"layout":"default","localId":"97799729-c6aa-4413-bd14-a5bdffd57826"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":155},"layout":"default","localId":"d25c2362-6eea-4f9f-92d4-3dfbb8925738"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":157},"layout":"default","localId":"4baa0995-b9a0-434f-b2d4-17778026c71e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":159},"layout":"default","localId":"8f79dd8d-a596-4ed8-b229-faed9a76958e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":161},"layout":"default","localId":"25e4fa75-6344-4c75-a5c1-4f88b184d6c7"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":164},"layout":"default","localId":"9163134d-d363-4379-8248-2d1ca595a8a4"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":166},"layout":"default","localId":"b43a9f78-4879-4120-82c8-da4c84a28e88"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":168},"layout":"default","localId":"71b6602c-710c-4836-9f79-521af63e9c33"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":170},"layout":"default","localId":"8acbafe8-cc3f-4741-9545-1877d6673686"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":172},"layout":"default","localId":"66ceb283-3a6b-4fdc-92aa-0c14e89bf0dc"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":174},"layout":"default","localId":"19cf9018-0112-4e81-8508-a9860f82f0ec"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":176},"layout":"default","localId":"486c3b95-8f1d-454a-ade8-61fed135acf9"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":178},"layout":"default","localId":"d30807b8-2c4f-4f69-bbd2-f55e8dfb7b70"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":180},"layout":"default","localId":"b1a00578-f4d9-42a1-b432-10226c11e3e5"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":182},"layout":"default","localId":"d67ee6ac-a7bf-42c5-9534-8c169640c956"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":184},"layout":"default","localId":"b81ce732-9c94-467f-b6dd-80b5f950fe2b"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":186},"layout":"default","localId":"9458593a-287a-4edf-98e4-783750e429bd"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":188},"layout":"default","localId":"b57d32be-f302-4cb4-a502-84714d44771e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":68},"layout":"default","localId":"3786461c-c0bc-437b-ba12-a7c1fd9fb1aa"}}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"e398cb8d-798e-44e1-95aa-51f15a2bca44"},"content":[{"type":"text","text":"Electronic Medical Record Data","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"cab3377b-aa96-4de4-a305-6b637b53f4d4"},"content":[{"type":"text","text":"Electronic Medical Record Data includes all available data from participant’s medical records."}]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":60},"layout":"default","localId":"e694a570-d7b6-497e-8b01-5b7016ca3f59"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":61},"layout":"default","localId":"53181c0c-e984-4c35-b467-4f03cacd4c06"}}]},{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":62},"layout":"default","localId":"7a25c264-0689-4fa1-a05c-7b5daa84995c"}}]}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":69},"layout":"default","localId":"7a536924-b8ee-4c75-b92b-067a22f7c09a"}}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"e398cb8d-798e-44e1-95aa-51f15a2bca44"},"content":[{"type":"text","text":"Data Services","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"42273805-bf2c-4c42-84f7-b44aac189e24"},"content":[{"type":"text","text":"A request for technical assistance. "}]},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":64},"layout":"default","localId":"55a60bd9-13dc-4c1b-892c-3a530654b1f1"}},{"type":"paragraph","content":[]}]},{"version":1,"type":"doc","content":[{"type":"heading","attrs":{"level":2,"localId":"1a8dd17f-d8e6-4920-82c0-c823b6d812ce"},"content":[{"type":"text","text":"Biosample Request","marks":[{"type":"strong"}]}]},{"type":"paragraph","attrs":{"localId":"6571af88-b9fe-4667-a080-49e6e9f5c99f"},"content":[{"type":"text","text":"Please enter the information below to request specific scientific testing/results on DREAM samples. "}]},{"type":"layoutSection","content":[{"type":"layoutColumn","attrs":{"width":33.33},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":29},"layout":"default","localId":"a6de2b5b-487c-4ace-a788-9a7b93bcccb2"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":38},"layout":"default","localId":"e5e5277e-2228-4cab-8338-7be1d9b5aa20"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":33},"layout":"default","localId":"fc872c5e-b1ee-46de-9f3a-f972b5e3b076"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":55},"layout":"default","localId":"fcec2065-85e9-4d65-a961-fffd72d96fd2"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":35},"layout":"default","localId":"9e0e8068-9502-4f97-9252-17820371200f"}},{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":36},"layout":"default","localId":"d303a075-3b10-4cc2-86bb-491b62324281"}}]},{"type":"layoutColumn","attrs":{"width":66.66},"content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":59},"layout":"default","localId":"84dd0b1a-258a-43c2-9f15-8dcf6016d696"}}]}]}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":190},"layout":"default","localId":"5250c057-8a58-4ab5-ac9f-7cc93a97a442"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":192},"layout":"default","localId":"f508efd9-5c78-44a1-b4ae-2c57928c99f6"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":194},"layout":"default","localId":"0f1e76a0-93de-4aa2-bb27-a99f37aa115c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":196},"layout":"default","localId":"fd102f26-9d14-4cb4-8f18-97856510fae9"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":198},"layout":"default","localId":"e5824432-2128-4121-a4d7-757de95bb6f6"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":200},"layout":"default","localId":"03fc04d8-a618-46bd-bc24-9a1a11dd20c1"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":202},"layout":"default","localId":"f8330f3f-d516-4680-9381-9fbffda69c93"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":204},"layout":"default","localId":"dc974222-c661-404f-9c87-9fa74d4cd2a0"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":206},"layout":"default","localId":"c05eed18-87a3-482e-b6c4-cab00083a968"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":208},"layout":"default","localId":"de4bc66a-b962-4b6e-bc5b-664c676eea6e"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":210},"layout":"default","localId":"bc885823-bd92-4034-a489-6ed6bd54d40b"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":212},"layout":"default","localId":"23942c06-ea91-45d5-a0ba-d9d54c03eb9c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":214},"layout":"default","localId":"dc0dedd9-691f-460e-840b-99ba6f53e14d"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":216},"layout":"default","localId":"1e119077-fbcb-4715-97d2-fba9218d98e5"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":218},"layout":"default","localId":"d2d548e5-8f2a-4aa5-88ec-054beea93692"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":220},"layout":"default","localId":"42886103-3857-4535-94cd-eba7a72db1cc"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":222},"layout":"default","localId":"8ca97437-b79b-4e82-8747-aac80614aa1c"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":224},"layout":"default","localId":"a7379868-e121-49c3-8956-b677365d02ee"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":226},"layout":"default","localId":"ddde84da-9027-4bd6-92b8-bcf0b9031aa0"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":228},"layout":"default","localId":"c1073b48-645c-4aec-a65f-788d486f8108"}}]},{"version":1,"type":"doc","content":[{"type":"extension","attrs":{"extensionKey":"question","extensionType":"com.thinktilt.proforma","parameters":{"id":234},"layout":"default","localId":"1f83d77f-511d-4690-ac48-2d92387e4f4c"}},{"type":"heading","attrs":{"level":2,"localId":"d3d35951-9b6d-4466-81fe-7012509edcff"},"content":[]},{"type":"paragraph","content":[]}]}],"conditions":{"124":{"i":{"co":{"cIds":{"123":["2"]}}},"o":{"sIds":["22"]},"t":"sh"},"175":{"i":{"co":{"cIds":{"174":["2"]}}},"o":{"sIds":["48"]},"t":"sh"},"227":{"i":{"co":{"cIds":{"226":["2"]}}},"o":{"sIds":["78"]},"t":"sh"},"134":{"i":{"co":{"cIds":{"104":["8"]}}},"o":{"sIds":["27"]},"t":"sh"},"116":{"i":{"co":{"cIds":{"115":["2"]}}},"o":{"sIds":["18"]},"t":"sh"},"225":{"i":{"co":{"cIds":{"36":["7"]}}},"o":{"sIds":["77"]},"t":"sh"},"189":{"i":{"co":{"cIds":{"36":["1"]}}},"o":{"sIds":["59"]},"t":"sh"},"167":{"i":{"co":{"cIds":{"166":["2"]}}},"o":{"sIds":["44"]},"t":"sh"},"229":{"i":{"co":{"cIds":{"96":["10005"]}}},"o":{"sIds":["33"]},"t":"sh"},"205":{"i":{"co":{"cIds":{"36":["6"]}}},"o":{"sIds":["67"]},"t":"sh"},"169":{"i":{"co":{"cIds":{"147":["5"]}}},"o":{"sIds":["45"]},"t":"sh"},"120":{"i":{"co":{"cIds":{"119":["2"]}}},"o":{"sIds":["20"]},"t":"sh"},"193":{"i":{"co":{"cIds":{"36":["2"]}}},"o":{"sIds":["61"]},"t":"sh"},"93":{"i":{"co":{"cIds":{"90":["4"]}}},"o":{"sIds":["9"]},"t":"sh"},"158":{"i":{"co":{"cIds":{"157":["2"]}}},"o":{"sIds":["40"]},"t":"sh"},"142":{"i":{"co":{"cIds":{"104":["7"]}}},"o":{"sIds":["31"]},"t":"sh"},"223":{"i":{"co":{"cIds":{"222":["2"]}}},"o":{"sIds":["76"]},"t":"sh"},"66":{"i":{"co":{"cIds":{"96":["10008"]}}},"o":{"sIds":["57"]},"t":"sh"},"128":{"i":{"co":{"cIds":{"127":["2"]}}},"o":{"sIds":["24"]},"t":"sh"},"40":{"i":{"co":{"cIds":{"96":["10005"]}}},"o":{"sIds":["12"]},"t":"sh"},"110":{"i":{"co":{"cIds":{"104":["2"]}}},"o":{"sIds":["15"]},"t":"sh"},"181":{"i":{"co":{"cIds":{"147":["9"]}}},"o":{"sIds":["51"]},"t":"sh"},"132":{"i":{"co":{"cIds":{"131":["2"]}}},"o":{"sIds":["26"]},"t":"sh"},"201":{"i":{"co":{"cIds":{"36":["3"]}}},"o":{"sIds":["65"]},"t":"sh"},"197":{"i":{"co":{"cIds":{"36":["8"]}}},"o":{"sIds":["63"]},"t":"sh"},"217":{"i":{"co":{"cIds":{"36":["10"]}}},"o":{"sIds":["73"]},"t":"sh"},"177":{"i":{"co":{"cIds":{"147":["8"]}}},"o":{"sIds":["49"]},"t":"sh"},"24":{"i":{"co":{"cIds":{"96":["10004"]}}},"o":{"sIds":["11"]},"t":"sh"},"209":{"i":{"co":{"cIds":{"36":["5"]}}},"o":{"sIds":["69"]},"t":"sh"},"233":{"i":{"co":{"cIds":{"36":["11"]}}},"o":{"sIds":["79"]},"t":"sh"},"152":{"i":{"co":{"cIds":{"147":["2"]}}},"o":{"sIds":["37"]},"t":"sh"},"112":{"i":{"co":{"cIds":{"111":["2"]}}},"o":{"sIds":["16"]},"t":"sh"},"199":{"i":{"co":{"cIds":{"198":["2"]}}},"o":{"sIds":["64"]},"t":"sh"},"144":{"i":{"co":{"cIds":{"143":["2"]}}},"o":{"sIds":["32"]},"t":"sh"},"138":{"i":{"co":{"cIds":{"104":["9"]}}},"o":{"sIds":["29"]},"t":"sh"},"148":{"i":{"co":{"cIds":{"147":["1"]}}},"o":{"sIds":["35"]},"t":"sh"},"65":{"i":{"co":{"cIds":{"96":["10007"]}}},"o":{"sIds":["56"]},"t":"sh"},"213":{"i":{"co":{"cIds":{"36":["4"]}}},"o":{"sIds":["71"]},"t":"sh"},"108":{"i":{"co":{"cIds":{"107":["2"]}}},"o":{"sIds":["14"]},"t":"sh"},"185":{"i":{"co":{"cIds":{"147":["7"]}}},"o":{"sIds":["53"]},"t":"sh"},"219":{"i":{"co":{"cIds":{"218":["2"]}}},"o":{"sIds":["74"]},"t":"sh"},"106":{"i":{"co":{"cIds":{"104":["1"]}}},"o":{"sIds":["13"]},"t":"sh"},"82":{"i":{"co":{"cIds":{"81":["1"]}}},"o":{"sIds":["6"]},"t":"sh"},"126":{"i":{"co":{"cIds":{"104":["5"]}}},"o":{"sIds":["23"]},"t":"sh"},"140":{"i":{"co":{"cIds":{"139":["2"]}}},"o":{"sIds":["30"]},"t":"sh"},"173":{"i":{"co":{"cIds":{"147":["10"]}}},"o":{"sIds":["47"]},"t":"sh"},"221":{"i":{"co":{"cIds":{"36":["9"]}}},"o":{"sIds":["75"]},"t":"sh"},"122":{"i":{"co":{"cIds":{"104":["6"]}}},"o":{"sIds":["21"]},"t":"sh"},"230":{"i":{"co":{"cIds":{"96":["10006"]}}},"o":{"sIds":["55"]},"t":"sh"},"162":{"i":{"co":{"cIds":{"161":["2"]}}},"o":{"sIds":["42"]},"t":"sh"},"191":{"i":{"co":{"cIds":{"190":["2"]}}},"o":{"sIds":["60"]},"t":"sh"},"203":{"i":{"co":{"cIds":{"202":["2"]}}},"o":{"sIds":["66"]},"t":"sh"},"195":{"i":{"co":{"cIds":{"194":["2"]}}},"o":{"sIds":["62"]},"t":"sh"},"156":{"i":{"co":{"cIds":{"147":["3"]}}},"o":{"sIds":["39"]},"t":"sh"},"160":{"i":{"co":{"cIds":{"147":["4"]}}},"o":{"sIds":["41"]},"t":"sh"},"118":{"i":{"co":{"cIds":{"104":["4"]}}},"o":{"sIds":["19"]},"t":"sh"},"187":{"i":{"co":{"cIds":{"186":["2"]}}},"o":{"sIds":["54"]},"t":"sh"},"171":{"i":{"co":{"cIds":{"170":["2"]}}},"o":{"sIds":["46"]},"t":"sh"},"165":{"i":{"co":{"cIds":{"147":["6"]}}},"o":{"sIds":["43"]},"t":"sh"},"235":{"i":{"co":{"cIds":{"81":["2"]}}},"o":{"sIds":["7"]},"t":"sh"},"92":{"i":{"co":{"cIds":{"90":["3"]}}},"o":{"sIds":["5"]},"t":"sh"},"154":{"i":{"co":{"cIds":{"153":["2"]}}},"o":{"sIds":["38"]},"t":"sh"},"215":{"i":{"co":{"cIds":{"214":["2"]}}},"o":{"sIds":["72"]},"t":"sh"},"183":{"i":{"co":{"cIds":{"182":["2"]}}},"o":{"sIds":["52"]},"t":"sh"},"97":{"i":{"co":{"cIds":{"79":["1"]}}},"o":{"sIds":["4"]},"t":"sh"},"114":{"i":{"co":{"cIds":{"104":["3"]}}},"o":{"sIds":["17"]},"t":"sh"},"130":{"i":{"co":{"cIds":{"104":["10"]}}},"o":{"sIds":["25"]},"t":"sh"},"179":{"i":{"co":{"cIds":{"178":["2"]}}},"o":{"sIds":["50"]},"t":"sh"},"207":{"i":{"co":{"cIds":{"206":["2"]}}},"o":{"sIds":["68"]},"t":"sh"},"41":{"i":{"co":{"cIds":{"96":["10006"]}}},"o":{"sIds":["34"]},"t":"sh"},"211":{"i":{"co":{"cIds":{"210":["2"]}}},"o":{"sIds":["70"]},"t":"sh"},"150":{"i":{"co":{"cIds":{"149":["2"]}}},"o":{"sIds":["36"]},"t":"sh"},"91":{"i":{"co":{"cIds":{"90":["2"]}}},"o":{"sIds":["3"]},"t":"sh"},"85":{"i":{"co":{"cIds":{"81":["2"]}}},"o":{"sIds":["8"]},"t":"sh"},"28":{"i":{"co":{"cIds":{"96":["10009"]}}},"o":{"sIds":["58"]},"t":"sh"},"136":{"i":{"co":{"cIds":{"135":["2"]}}},"o":{"sIds":["28"]},"t":"sh"}},"sections":{"18":{"name":"scRNAseq No","conditions":["116"]},"52":{"name":"Spectral Flow No","conditions":["183"]},"28":{"name":"CyToF No","conditions":["136"]},"45":{"name":"Aabs Information","conditions":["169"]},"34":{"name":"Tier 3 Data Request","conditions":["41"]},"67":{"name":"Microbiome Information","conditions":["205"]},"12":{"name":"Tier 2 Data Request","conditions":["40"]},"66":{"name":"TCR-BCR No","conditions":["203"]},"51":{"name":"Spectral Flow Information","conditions":["181"]},"8":{"name":"Pending Grant Other Source","conditions":["85"]},"73":{"name":"CyToF Information","conditions":["217"]},"78":{"name":"HCQ No","conditions":["227"]},"19":{"name":"TCR-BCR Sequencing Information","conditions":["118"]},"23":{"name":"Aabs Information","conditions":["126"]},"62":{"name":"Bulk RNAseq No","conditions":["195"]},"4":{"name":"Current LRA Grant Mechanism","conditions":["97"]},"77":{"name":"HCQ Levels Information","conditions":["225"]},"40":{"name":"scRNAseq No","conditions":["158"]},"15":{"name":"Bulk RNAseq Information","conditions":["110"]},"11":{"name":"Tier 1 Data Request","conditions":["24"]},"9":{"name":"No Funding","conditions":["93"]},"44":{"name":"Microbial Metagenomics No","conditions":["167"]},"33":{"name":"Additional Information","conditions":["229"]},"22":{"name":"Microbial Metagenomics No","conditions":["124"]},"56":{"name":"Electronic Medical record data","conditions":["65"]},"55":{"name":"Additional Information","conditions":["230"]},"26":{"name":"Proteomics No","conditions":["132"]},"50":{"name":"CyToF No","conditions":["179"]},"37":{"name":"Bulk RNAseq Information","conditions":["152"]},"68":{"name":"Microbial Metagenomics No","conditions":["207"]},"61":{"name":"Bulk RNAseq Information","conditions":["193"]},"13":{"name":"WGS Information","conditions":["106"]},"46":{"name":"Aabs No","conditions":["171"]},"24":{"name":"Aabs No","conditions":["128"]},"35":{"name":"WGS Information","conditions":["148"]},"16":{"name":"Bulk RNAseq No","conditions":["112"]},"79":{"name":"Other Assay(s)","conditions":["233"]},"5":{"name":"Pending Grant Award","conditions":["92"]},"72":{"name":"Proteomics No","conditions":["215"]},"10":{"conditions":[]},"59":{"name":"WGS Information","conditions":["189"]},"48":{"name":"Proteomics No","conditions":["175"]},"21":{"name":"Microbiome Information","conditions":["122"]},"76":{"name":"Spectral Flow No","conditions":["223"]},"54":{"name":"HCQ No","conditions":["187"]},"43":{"name":"Microbiome Information","conditions":["165"]},"65":{"name":"TCR-BCR Sequencing Information","conditions":["201"]},"71":{"name":"Proteomics Information","conditions":["213"]},"57":{"name":"data services","conditions":["66"]},"32":{"name":"HCQ No","conditions":["144"]},"49":{"name":"CyToF Information","conditions":["177"]},"6":{"name":"Pending Grant LRA Mech","conditions":["82"]},"36":{"name":"WGS No","conditions":["150"]},"1":{"conditions":[]},"39":{"name":"scRNAseq Information","conditions":["156"]},"17":{"name":"scRNAseq Information","conditions":["114"]},"25":{"name":"Proteomics Information","conditions":["130"]},"60":{"name":"WGS No","conditions":["191"]},"14":{"name":"WGS No","conditions":["108"]},"47":{"name":"Proteomics Information","conditions":["173"]},"31":{"name":"HCQ Levels Information","conditions":["142"]},"69":{"name":"Aabs Information","conditions":["209"]},"58":{"name":"Biosample Request","conditions":["28"]},"64":{"name":"scRNAseq No","conditions":["199"]},"53":{"name":"HCQ Levels Information","conditions":["185"]},"42":{"name":"TCR-BCR No","conditions":["162"]},"75":{"name":"Spectral Flow Information","conditions":["221"]},"20":{"name":"TCR-BCR No","conditions":["120"]},"27":{"name":"CyToF Information","conditions":["134"]},"70":{"name":"Aabs No","conditions":["211"]},"2":{"name":"Academia Researchers","conditions":[]},"38":{"name":"Bulk RNAseq No","conditions":["154"]},"30":{"name":"Spectral Flow No","conditions":["140"]},"7":{"name":"Other Funding Source","conditions":["235"]},"29":{"name":"Spectral Flow Information","conditions":["138"]},"41":{"name":"TCR-BCR Sequencing Information","conditions":["160"]},"63":{"name":"scRNAseq Information","conditions":["197"]},"3":{"name":"Current Grant Award","conditions":["91"]},"74":{"name":"CyToF No","conditions":["219"]}},"questions":{"121":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the TCR-BCR Sequencing methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"115":{"type":"cd","label":"scRNAseq Methodology","description":"We will be performing scRNAseq on unsorted and unstimulated PBMCs via: 10X Genomics Chromium X series, sequenced on an Illumina NovaSeq X plus or equivalent, with a capture target of 3,000 cells per sample and a depth of at least 50,000 reads per cell. Would this sequencing be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"198":{"type":"cd","label":"scRNAseq Methodology","description":"We will be performing scRNAseq on unsorted and unstimulated PBMCs via: 10X Genomics Chromium X series, sequenced on an Illumina NovaSeq X plus or equivalent, with a capture target of 3,000 cells per sample and a depth of at least 50,000 reads per cell. Would this sequencing be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"45":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"8","label":"21 Month Visit","other":false},{"id":"9","label":"24 Month Visit","other":false},{"id":"10","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"98":{"type":"cd","label":"Lupus Research Alliance Grant Mechanism","description":"Select only one","validation":{"rq":true},"choices":[{"id":"1","label":"Cross Collaborative GTSA Supplement (CCGS)","other":false},{"id":"2","label":"Common Mechanisms in Autoimmunity Insight Award (CMIA)","other":false},{"id":"3","label":"Empowering Lupus Research-Administrative Supplement (ELRAS)","other":false},{"id":"4","label":"Empowering Lupus Research-Career Development Award (ELR-CDA)","other":false},{"id":"5","label":"Empowering Lupus Research-Post-Doctoral Award (ELR-PDA)","other":false},{"id":"6","label":"Rheumatology Research Foundation-Scientist Development Award (RRF-SDA)","other":false},{"id":"7","label":"Engineered Cell Therapies (ECT)","other":false},{"id":"8","label":"Global Team Science Award (GTSA)","other":false},{"id":"9","label":"Lupus Innovation Award (LIA)","other":false},{"id":"10","label":"Mechanistic Clinical Award (MCA)","other":false},{"id":"11","label":"Translational Bridge Award (TBA)","other":false}],"questionKey":""},"113":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Bulk RNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"67":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding cases and timepoints.","validation":{"rq":false},"choices":[],"questionKey":""},"153":{"type":"cd","label":"Bulk RNAseq Methodology","description":"We will we performing bulk RNAseq stemming from PaxGene tubes, and it will be performed using the NEBNext-Ultra II RNA library preparation kit, and then sequenced to ~20M reads/sample or 6Gb/sample, for differential gene expression analysis. Sequencing will be performed on the NovaSeq X Plus platform at a 2x150bp configuration. In your experience, would this protocol be adequate to pick up on expression levels of your gene(s) of interest?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"182":{"type":"cd","label":"Spectral Flow Methodology","description":"We will be performing Spectral Flow Cytometry on unsorted and unstimulated PBMCs via: The Cytek Aurora, which has a 5 laser configuration, 40 colors, and 67 parameters. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"147":{"type":"cl","label":"Type of Biomarker Data","description":"Select the requested analysis below (select all that apply).","validation":{"rq":true,"mns":1},"choices":[{"id":"1","label":"Whole Genome Sequencing","other":false},{"id":"2","label":"Bulk RNA Sequencing","other":false},{"id":"3","label":"Single-Cell RNA Sequencing","other":false},{"id":"4","label":"TCR and/or BCR Sequencing","other":false},{"id":"6","label":"Microbial Metagenomics","other":false},{"id":"5","label":"Auto-Antibodies (Lupus-Associated)","other":false},{"id":"10","label":"Proteomics","other":false},{"id":"8","label":"CyToF","other":false},{"id":"9","label":"Spectral Flow Cytometry","other":false},{"id":"7","label":"Hydroxychloroquine Medication Levels","other":false},{"id":"11","label":"DxTerity IFN-1 MIP Assay","other":false}],"questionKey":""},"51":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"8","label":"21 Month Visit","other":false},{"id":"9","label":"24 Month Visit","other":false},{"id":"10","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"216":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Proteomics methodology above.","description":"Please include any proteins not found in the Olink platform mentioned above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"89":{"type":"rt","label":"Please explain further how this research will be financially supported.","description":"","validation":{"rq":false},"choices":[],"questionKey":""},"84":{"type":"da","label":"Date of Anticipated LRA Funding Source","description":"Please select a date","validation":{"rq":true},"choices":[],"questionKey":""},"164":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the TCR-BCR Sequencing methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"170":{"type":"cd","label":"Aabs Methodology","description":"We will be measuring lupus-associated auto-antibodies (Aabs): ANA, C1q, B2GP1, KIF20B, NMDAR2, Cardiolipin, dsDNA, SSB/La, SSA/Ro60, TRIM21/Ro52, RNP, Sm, Scl-70, Centromere, Ribosomal P, Jo-1, DFS70. Would those datasets be sufficient for your Aab needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"19":{"type":"ts","label":"Company/Institution","description":"Company or institution name.","validation":{"rq":true},"choices":[],"questionKey":""},"62":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"8","label":"21 Month Visit","other":false},{"id":"9","label":"24 Month Visit","other":false},{"id":"10","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"135":{"type":"cd","label":"CyToF Methodology","description":"We will be performing CyToF on unsorted and unstimulated PBMCs via: The CyTOF XT, set to acquire 300,000 events. The current assay can easily be made customizable with up to 47 parameters per sample. The final panel of choice can include surface, intracellular, and even intra nuclear markers all within the same tube. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"15":{"type":"cd","label":"Company/Institution Type","description":"Type of Institution.","validation":{"rq":true},"jiraField":"customfield_10351","questionKey":""},"104":{"type":"cl","label":"Type of Biomarker Data","description":"Select the requested analysis below (select all that apply).","validation":{"rq":true,"mns":1},"choices":[{"id":"1","label":"Whole Genome Sequencing","other":false},{"id":"2","label":"Bulk RNA Sequencing","other":false},{"id":"3","label":"Single-Cell RNA Sequencing","other":false},{"id":"4","label":"TCR and/or BCR Sequencing","other":false},{"id":"6","label":"Microbial Metagenomics","other":false},{"id":"5","label":"Auto-Antibodies (Lupus-Associated)","other":false},{"id":"10","label":"Proteomics","other":false},{"id":"8","label":"CyToF","other":false},{"id":"9","label":"Spectral Flow Cytometry","other":false},{"id":"7","label":"Hydroxychloroquine Medication Levels","other":false},{"id":"11","label":"DxTerity IFN-1 MIP Assay","other":false}],"questionKey":""},"90":{"type":"cl","label":"Funding Source","description":"Select your funding source. You can select more than one.","validation":{"rq":true},"choices":[{"id":"1","label":"Institutional/Organizational Funds","other":false},{"id":"2","label":"Current Grant Award","other":false},{"id":"3","label":"Pending Grant Award","other":false},{"id":"4","label":"No Funding","other":false}],"questionKey":""},"141":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Spectral Flow Cytometry methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"139":{"type":"cd","label":"Spectral Flow Methodology","description":"We will be performing Spectral Flow Cytometry on unsorted and unstimulated PBMCs via: The Cytek Aurora, which has a 5 laser configuration, 40 colors, and 67 parameters. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"33":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"117":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the scRNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"186":{"type":"cd","label":"HCQ Methodology","description":"We will be measuring hydroxychloroquine (HCQ) levels in participants currently taking the medication via: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS), which provides the concentration of HCQ measured in nanograms/milliliter. Would this be adequate for your project’s needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"55":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"8","label":"21 Month Visit","other":false},{"id":"9","label":"24 Month Visit","other":false},{"id":"10","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"212":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Auto-Antibody methodology above.","description":"Please include any Aabs not found in the list above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"50":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"123":{"type":"cd","label":"Microbial Metagenomics Methodology","description":"We will be performing microbial metagenomics on stool samples where gDNA is extracted using an optimized and validated extraction method (QIAGEN Powersoil Pro) and sequenced on an Illumina NovaSeq X platform or Element AVITI platform (or equivalent at time of processing) on a 2X150bp specification. Would those datasets be sufficient for your microbiome needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"174":{"type":"cd","label":"Proteomics Methodology","description":"We will have proteomics data on plasma, and we will be using the Olink Explore HT assay (over 6,000 proteins). Would those datasets be sufficient for your proteomics needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"68":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding cases, timepoints, or assays","validation":{"rq":false,"mxw":100},"choices":[],"questionKey":""},"26":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"224":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Spectral Flow Cytometry methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"166":{"type":"cd","label":"Microbial Metagenomics Methodology","description":"We will be performing microbial metagenomics on stool samples where gDNA is extracted using an optimized and validated extraction method (QIAGEN Powersoil Pro) and sequenced on an Illumina NovaSeq X platform or Element AVITI platform (or equivalent at time of processing) on a 2X150bp specification. Would those datasets be sufficient for your microbiome needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"61":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"107":{"type":"cd","label":"WGS Methodology","description":"We will have WGS performed for all individuals in our study, and all libraries will be dual-barcoded and sequenced with 150bp paired-end reads on the Illumina NovaSeq X Plus platform with at least 30X depth. In your experience, would this protocol be adequate to pick up on the mutations you are interested in?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"46":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"206":{"type":"cd","label":"Microbial Metagenomics Methodology","description":"We will be performing microbial metagenomics on stool samples where gDNA is extracted using an optimized and validated extraction method (QIAGEN Powersoil Pro) and sequenced on an Illumina NovaSeq X platform or Element AVITI platform (or equivalent at time of processing) on a 2X150bp specification. Would those datasets be sufficient for your microbiome needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"155":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Bulk RNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"83":{"type":"cd","label":"Lupus Research Alliance Grant Mechanism","description":"Select only one","validation":{"rq":true},"jiraField":"customfield_10451","questionKey":""},"35":{"type":"ts","label":"Sample Volume or Cell Number per Timepoint","description":"Enter the sample volume or cell number required","validation":{"rq":true},"choices":[],"questionKey":""},"192":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the WGS methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"79":{"type":"cl","label":"Current Grant Source","description":"You can select more than one","validation":{"rq":true},"choices":[{"id":"1","label":"Lupus Research Alliance","other":false},{"id":"0","label":"Other...","other":true}],"questionKey":""},"5":{"type":"te","label":"Email","description":"What's your email address?","validation":{"rq":true},"choices":[],"questionKey":""},"159":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the scRNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"59":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding your request","validation":{"rq":false},"choices":[],"questionKey":""},"237":{"type":"rt","label":"Please describe the funding source for which your grant is pending","description":"","validation":{"rq":true},"choices":[],"questionKey":""},"196":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Bulk RNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"48":{"type":"cl","label":"Timepoints per Case","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"Enrollment (does not correlate with disease onset)","other":false},{"id":"2","label":"3 Month Visit","other":false},{"id":"3","label":"6 Month Visit","other":false},{"id":"4","label":"9 Month Visit","other":false},{"id":"5","label":"12 Month Visit","other":false},{"id":"6","label":"15 Month Visit","other":false},{"id":"7","label":"18 Month Visit","other":false},{"id":"10","label":"21 Month Visit","other":false},{"id":"8","label":"24 Month Visit","other":false},{"id":"9","label":"30 Month Visit","other":false},{"id":"11","label":"36 Month Visit","other":false},{"id":"12","label":"42 Month Visit","other":false},{"id":"13","label":"48 Month Visit","other":false},{"id":"14","label":"54 Month Visit","other":false},{"id":"15","label":"60 Month Visit","other":false},{"id":"16","label":"Unscheduled Visit","other":false}],"questionKey":""},"21":{"type":"rt","label":"Research Abstract","description":"Please give a description of your research project and how the DREAM can help.","validation":{"rq":true,"mxw":1000},"jiraField":"description","questionKey":""},"228":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the HCQ medication level methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"188":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the HCQ medication level methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"127":{"type":"cd","label":"Aabs Methodology","description":"We will be measuring lupus-associated auto-antibodies (Aabs): ANA, C1q, B2GP1, KIF20B, NMDAR2, Cardiolipin, dsDNA, SSB/La, SSA/Ro60, TRIM21/Ro52, RNP, Sm, Scl-70, Centromere, Ribosomal P, Jo-1, DFS70. Would those datasets be sufficient for your Aab needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"57":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding cases, timepoints, or assays","validation":{"rq":false,"mxw":100},"choices":[],"questionKey":""},"202":{"type":"cd","label":"TCR-BCR Sequencing Methodology","description":"We will be performing a 7-chain TCR and BCR assay using a multiplex PCR assay that simultaneously captures the immune repertoire of both TCRs and BCRs in the same reaction (T-cell receptor α, β, δ, ɣ, and B-cell Ig κ and λ; all isotypes). The resultant, error corrected, and mapped immune adaptome data include the RNA frequency or expression of each clonotype or unique V-J-uCDR3 (uCDR3) expression inclusive of V-, (D-), J- gene segment annotation and frequency, and several sample related diversity metrics including D50, diversity index, shannon entropy, and Pielou’s evenness. Sequencing is performed on the Illumina NextSeq P2 (600-cycle, XLEAP) in paired end read (PER) format. Would those datasets be sufficient for your TCR/BCR needs? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"234":{"type":"rt","label":"Other Intended Analyses","description":"Please describe any other intended analyses for the biosamples.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"137":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the CyToF methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"49":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"36":{"type":"cl","label":"Intended Analyses","description":"Select the intended analyses below (select all that apply). If \"Other\" is chosen, please use the \"Notes\" field to elaborate on the desired analyses.","validation":{"rq":true},"choices":[{"id":"1","label":"Whole Genome Sequencing","other":false},{"id":"2","label":"Bulk RNA Sequencing","other":false},{"id":"8","label":"Single-Cell RNA Sequencing","other":false},{"id":"3","label":"TCR and/or BCR Sequencing","other":false},{"id":"6","label":"Microbial Metagenomics","other":false},{"id":"5","label":"Auto-Antibodies (Lupus-Associated)","other":false},{"id":"4","label":"Proteomics","other":false},{"id":"10","label":"CyToF","other":false},{"id":"9","label":"Spectral Flow Cytometry","other":false},{"id":"7","label":"Hydroxychloroquine Medication Levels","other":false},{"id":"11","label":"Other Assay(s)","other":false}],"questionKey":""},"1":{"type":"ts","label":"Name","description":"What's your name?","validation":{"rq":true},"choices":[],"questionKey":""},"180":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the CyToF methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"25":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"60":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"208":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Microbial Metagenomics methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"133":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Proteomics methodology above.","description":"Please include any proteins not found in the Olink platform mentioned above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"47":{"type":"no","label":"Total Number of Cases","description":"How many cases to include","validation":{"rq":true,"wh":false},"choices":[],"questionKey":""},"111":{"type":"cd","label":"Bulk RNAseq Methodology","description":"We will we performing bulk RNAseq stemming from PaxGene tubes, and it will be performed using the NEBNext-Ultra II RNA library preparation kit, and then sequenced to ~20M reads/sample or 6Gb/sample, for differential gene expression analysis. Sequencing will be performed on the NovaSeq X Plus platform at a 2x150bp configuration. In your experience, would this protocol be adequate to pick up on expression levels of your gene(s) of interest?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"151":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the WGS methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"95":{"type":"cd","label":"Technical Capabilities","description":"What are the technical capabilities of your team?","validation":{"rq":true},"choices":[{"id":"1","label":"No Code","other":false},{"id":"2","label":"Low Code (SQL, simple scripts)","other":false},{"id":"3","label":"Medium Code (Jupyter Notebook, Rstudio)","other":false},{"id":"4","label":"High Code (Nextflow, R, Python)","other":false},{"id":"0","label":"Other...","other":true}],"questionKey":""},"96":{"type":"cl","label":"Type of Request","description":"What kind of request do you want to make? Select all that apply.","validation":{"rq":true},"jiraField":"components","questionKey":""},"69":{"type":"rt","label":"Additional Information","description":"Please enter more detailed instructions regarding cases and timepoints","validation":{"rq":false,"mxw":100},"choices":[],"questionKey":""},"190":{"type":"cd","label":"WGS Methodology","description":"We will have WGS performed for all individuals in our study, and all libraries will be dual-barcoded and sequenced with 150bp paired-end reads on the Illumina NovaSeq X Plus platform with at least 30X depth. In your experience, would this protocol be adequate to pick up on the mutations you are interested in?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"145":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the HCQ medication level methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"184":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Spectral Flow Cytometry methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"64":{"type":"rt","label":"Data Service Request Instructions","description":"Please enter more detailed instructions regarding your request","validation":{"rq":false},"choices":[],"questionKey":""},"214":{"type":"cd","label":"Proteomics Methodology","description":"We will have proteomics data on plasma, and we will be using the Olink Explore HT assay (over 6,000 proteins). Would those datasets be sufficient for your proteomics needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"109":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the WGS methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"149":{"type":"cd","label":"WGS Methodology","description":"We will have WGS performed for all individuals in our study, and all libraries will be dual-barcoded and sequenced with 150bp paired-end reads on the Illumina NovaSeq X Plus platform with at least 30X depth. In your experience, would this protocol be adequate to pick up on the mutations you are interested in?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"20":{"type":"ts","label":"Project Title","description":"Name of your project.","validation":{"rq":true,"mxw":100},"jiraField":"summary","questionKey":""},"178":{"type":"cd","label":"CyToF Methodology","description":"We will be performing CyToF on unsorted and unstimulated PBMCs via: The CyTOF XT, set to acquire 300,000 events. The current assay can easily be made customizable with up to 47 per sample. The final panel of choice can include surface, intracellular, and even intra nuclear markers all within the same tube. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"210":{"type":"cd","label":"Aabs Methodology","description":"We will be measuring lupus-associated auto-antibodies (Aabs): ANA, C1q, B2GP1, KIF20B, NMDAR2, Cardiolipin, dsDNA, SSB/La, SSA/Ro60, TRIM21/Ro52, RNP, Sm, Scl-70, Centromere, Ribosomal P, Jo-1, DFS70. Would those datasets be sufficient for your Aab needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"86":{"type":"da","label":"Date of Anticipated Other Funding Source","description":"Please select a date","validation":{"rq":true},"choices":[],"questionKey":""},"38":{"type":"cl","label":"Types of Cases","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"1","label":"New Onset","other":false},{"id":"2","label":"Active Lupus Nephritis","other":false},{"id":"3","label":"Extra-Renal Flare","other":false},{"id":"4","label":"Prevalent/Quiescent","other":false}],"questionKey":""},"81":{"type":"cl","label":"Pending Grant Source","description":"You can select more than one","validation":{"rq":true},"choices":[{"id":"1","label":"Lupus Research Alliance","other":false},{"id":"2","label":"Other Funding Source","other":false}],"questionKey":""},"125":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Microbial Metagenomics methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"18":{"type":"ts","label":"Job Title","description":"What's your job title?","validation":{"rq":false},"choices":[],"questionKey":""},"194":{"type":"cd","label":"Bulk RNAseq Methodology","description":"We will we performing bulk RNAseq stemming from PaxGene tubes, and it will be performed using the NEBNext-Ultra II RNA library preparation kit, and then sequenced to ~20M reads/sample or 6Gb/sample, for differential gene expression analysis. Sequencing will be performed on the NovaSeq X Plus platform at a 2x150bp configuration. In your experience, would this protocol be adequate to pick up on expression levels of your gene(s) of interest?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"220":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the CyToF methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"7":{"type":"ts","label":"Phone","description":"What's your phone number?","validation":{"rq":false},"choices":[],"questionKey":""},"143":{"type":"cd","label":"HCQ Methodology","description":"We will be measuring hydroxychloroquine (HCQ) levels in participants currently taking the medication via: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS), which provides the concentration of HCQ measured in nanograms/milliliter. Would this be adequate for your project’s needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"218":{"type":"cd","label":"CyToF Methodology","description":"We will be performing CyToF on unsorted and unstimulated PBMCs via: The CyTOF XT, set to acquire 300,000 events. The current assay can easily be made customizable with up to 47 per sample. The final panel of choice can include surface, intracellular, and even intra nuclear markers all within the same tube. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"222":{"type":"cd","label":"Spectral Flow Methodology","description":"We will be performing Spectral Flow Cytometry on unsorted and unstimulated PBMCs via: The Cytek Aurora, which has a 5 laser configuration, 40 colors, and 67 parameters. Would this be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"129":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Auto-Antibody methodology above.","description":"Please include any Aabs not found in the list above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"29":{"type":"cl","label":"Sample Type(s)","description":"Select all that apply.","validation":{"rq":true},"choices":[{"id":"2","label":"Stool","other":false},{"id":"3","label":"PBMC","other":false},{"id":"4","label":"Serum","other":false},{"id":"5","label":"Plasma","other":false},{"id":"6","label":"Urine (whole)","other":false},{"id":"7","label":"Urine (cells)","other":false},{"id":"8","label":"Urine (supernatant)","other":false},{"id":"9","label":"RNA","other":false},{"id":"10","label":"gDNA","other":false},{"id":"11","label":"Saliva","other":false}],"questionKey":""},"168":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Microbial Metagenomics methodology above.","description":"","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"204":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the TCR-BCR Sequencing methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"226":{"type":"cd","label":"HCQ Methodology","description":"We will be measuring hydroxychloroquine (HCQ) levels in participants currently taking the medication via: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS), which provides the concentration of HCQ measured in nanograms/milliliter. Would this be adequate for your project’s needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"52":{"type":"cs","label":"Preferred Communication ","description":"What's the best way to reach you?","validation":{"rq":false},"choices":[{"id":"1","label":"Email","other":false},{"id":"2","label":"Phone","other":false}],"questionKey":""},"172":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Auto-Antibody methodology above.","description":"Please include any Aabs not found in the list above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"131":{"type":"cd","label":"Proteomics Methodology","description":"We will have proteomics data on plasma, and we will be using the Olink Explore HT assay (over 6,000 proteins). Would those datasets be sufficient for your proteomics needs?","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"200":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the scRNAseq methodology above.","description":"Please include details pertaining to any cell sorting, stimulation, or other conditions.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""},"119":{"type":"cd","label":"TCR-BCR Sequencing Methodology","description":"We will be performing a 7-chain TCR and BCR assay using a multiplex PCR assay that simultaneously captures the immune repertoire of both TCRs and BCRs in the same reaction (T-cell receptor α, β, δ, ɣ, and B-cell Ig κ and λ; all isotypes). The resultant, error corrected, and mapped immune adaptome data include the RNA frequency or expression of each clonotype or unique V-J-uCDR3 (uCDR3) expression inclusive of V-, (D-), J- gene segment annotation and frequency, and several sample related diversity metrics including D50, diversity index, Shannon entropy, and Pielou’s evenness. Sequencing is performed on the Illumina NextSeq P2 (600-cycle, XLEAP) in paired end read (PER) format. Would those datasets be sufficient for your TCR/BCR needs? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"161":{"type":"cd","label":"TCR-BCR Sequencing Methodology","description":"We will be performing a 7-chain TCR and BCR assay using a multiplex PCR assay that simultaneously captures the immune repertoire of both TCRs and BCRs in the same reaction (T-cell receptor α, β, δ, ɣ, and B-cell Ig κ and λ; all isotypes). The resultant, error corrected, and mapped immune adaptome data include the RNA frequency or expression of each clonotype or unique V-J-uCDR3 (uCDR3) expression inclusive of V-, (D-), J- gene segment annotation and frequency, and several sample related diversity metrics including D50, diversity index, shannon entropy, and Pielou’s evenness. Sequencing is performed on the Illumina NextSeq P2 (600-cycle, XLEAP) in paired end read (PER) format. Would those datasets be sufficient for your TCR/BCR needs? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"157":{"type":"cd","label":"scRNAseq Methodology","description":"We will be performing scRNAseq on unsorted and unstimulated PBMCs via: 10X Genomics Chromium X series, sequenced on an Illumina NovaSeq X plus or equivalent, with a capture target of 3,000 cells per sample and a depth of at least 50,000 reads per cell. Would this sequencing be adequate for your project? (Note: Please select \"No\" and explain further if you require cell sorting and/or stimulation or other conditions.)","validation":{"rq":true},"choices":[{"id":"1","label":"Yes","other":false},{"id":"2","label":"No (please explain)","other":false}],"questionKey":""},"176":{"type":"rt","label":"Please explain the difference(s) in methodology between your project's needs and the Proteomics methodology above.","description":"Please include any proteins not found in the Olink platform mentioned above.","validation":{"rq":true,"mnw":5},"choices":[],"questionKey":""}}},"uuid":"ce7605d7-5892-4597-838a-8cbc2367fcac"},"linkedJiraFields":["summary","components","description","customfield_10351","customfield_10451"]},"key":""},"portalWebFragments":{"headerPanels":[],"subheaderPanels":[],"footerPanels":[],"pagePanels":{"propertyPanels":[],"legacyPropertyPanels":[]}}}